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ABSTRACT 
Eric Adam Vitriol  
Using Microscopy to Manipulate and Visualize Signal Transduction in Living Cells 
(Under the direction of Ken Jacobson, Ph.D. and Klaus Hahn, Ph.D.) 
 
 Signaling events in cells are often localized and transient. Understanding how 
these pathways are regulated in space and time requires the development of new tools 
that reveal spatiotemporal transduction. Subcellular events can be visualized in real-time 
by high-resolution light microscopy. Technological advances in live-cell imaging have 
offered the means to not only observe the phenotypic consequences of signaling events, 
but to visualize and manipulate the activity of their components. This dissertation 
describes four studies in which microscopy is implemented to manipulate or visualize 
signal transduction in living cells. The first study demonstrates contributions to 
Chromophore Assisted Laser Inactivation, a light-mediated loss of function tool. The 
second study describes the generation of a new probe to visualize the activation of Src-
family kinases. The third study utilizes a biosensor for the GTPase RhoA to reveal novel 
information about how this signaling component is spatiotemporally regulated in 
neurons. Finally, the fourth study describes a new computational method for the 
automated identification and tracking of protein structures called focal adhesions. 
Together these studies demonstrate the power of using microscopy to gain key insights to 




 To my daughter Josefine, who forced me to make my time spent in the 
lab important so that I could spend every other moment with her.  
 
 To my wife Tracy-Ann, who always made it look so easy.  
 




I would like to specifically acknowledge the following people who have helped shape my 
scientific career: 
 
- My advisors Dr. Ken Jacobson and Dr. Klaus Hahn. It has been an honor and a privilege 
studying under you both. I became the scientist I am today mainly through the 
experiences and opportunities you provided.   
 
- My committee members Dr. Gary Johnson, Dr. Keith Burridge, and Dr. James Bear. 
Thank you for your enthusiasm, guidance, and support. I feel fortunate to have a 
committee composed of scientists that I have great admiration for.  
 
- Dr. Louis Hodgson, who taught me more about microscopy than any other; and who 
showed me almost any experiment is possible if approached through determination, 
hard work, and creativity.  
 
- Dr. Vytas Bankaitis, whose Grantsmanship class for second-year graduate students was     
the best educational experience of my academic career.  
 
 v
- Dr. Richard Cheney. It was during my interview with him watching movies of Myosin 
X motility in filopodia that made me realize that I needed to become a microscopist.   
 
- Dr. Charlie Ray (Palm Beach Community College), the best teacher that I ever had. 
Because I enjoyed his classes so much, I took them all. Before I knew it I was majoring 
in biology and my career path was set in motion.  
 
- To all of my other colleagues and collaborators, to numerous to name. I have had so 
many positive experiences in my time as an undergraduate, research technician, and 
graduate student at the University of North Carolina at Chapel Hill. Thank you for 
helping to make the last years of my life so worthwhile.  
 vi
TABLE OF CONTENTS 
LIST OF TABLES……….……………………………………………….....ix 
LIST OF FIGURES……………………………….……………………….....x 
LIST OF ABBREVIATIONS……….…………………………………......xii 
CHAPTER 1: Introduction. ......................................................................…...1 
Overview………..……………………………………………….…….1 
Chromophore Assisted Laser Inactivation............................................2 
Methods for CALI.......................................................................3 
Mechanism of Inactivation by CALI..........................................7 







CHAPTER 2: Enhanced EGFP-CALI using deficient cells rescued with 







CHAPTER 3: A Biosensor for Endogenous Src-Family Kinase  




Results and Discussion........…………………………………………48 
Methods...............................................................................................57 
CHAPTER 4: The Spatiotemporal Activation of RhoA during  
Growth Cone Advance and Collapse.............................................................62 
Abstract................................................................................................63 
Introduction….………………………………………………….……63 
Results and Discussion.....…...………………………………………67 
Methods...............................................................................................74 
CHAPTER 5: Automated Identification and Tracking of Focal 
Adhesions Reveals Phosphorylation of Paxillin at Serine 178 









LIST OF TABLES 
Table 2.1 Cytoplasmic mobility of Capping Protein and Mena…...………34 
 
 x
LIST OF FIGURES 
Figure 1.1. CALI schematic............................................................................3 
Figure 1.2. Localization vs. activation of signaling proteins........................12 
Figure 1.3. Biosensor schematic...................................................................17 
Figure 2.1. A lentiviral system for simultaneous knockdown  
and rescue with a functional EGFP-fusion complement……….....………..27 
 
Figure 2.2. CALI of EGFP-CP induces the formation of dorsal  
ruffles and filopodia only in the knockdown/rescue background…………..29 
 
Figure 2.3. CALI of EGFP-CP in KDR cells generates a local  
increase in barbed ends of actin filaments and dorsal F-actin……………...31 
 
Figure 2.4. CALI of EGFP-Mena in Mena/VASP deficient  
cells induces more stable lamellipodial protrusions.……………………….33 
 
Figure 3.1. FN3 domain-based monobody 1F11 shows preferential  
binding to active Src......................................................................................49 
 
Figure 3.2. Design and in vitro validation of 1F11 Src biosensor............... 52 
 
Figure 3.3. Spatiotemporal activation of endogenous SFKs  
in living cells..................................................................................................55 
 
Figure 4.1. Localization of RhoA activation in growth cones......................66 
Figure 4.2. Controls for localization of RhoA activity.................................68 
Figure 4.3. RhoA activation and microtubule polymerization  
are inversely related in the growth cone........................................................69 
 
Figure 4.4. Dynamics of RhoA activation in advancing  
growth cones..................................................................................................70 
 
Figure 4.5. RhoA activation during growth cone collapse...........................71 
 xi
Figure 4.6. Controls for RhoA activity change following LPA 
stimulation......................................................................................................73 
 
Figure 4.7. Summary of all LPA-induced collapse experiments..................73 
Figure 5.1. Automating the analysis of focal adhesion images  
requires a multi-stage pipeline.......................................................................80 
 
Figure 5.2. Applying quantitative image processing methods to  
images allows comprehensive characterization of FA properties..................82 
 
Figure 5.3. Automated measurement of focal adhesion dynamics...............83 
Figure 5.4. The assembly and disassembly log-linear models  
fit the Paxillin intensity time courses with high R values..............................84 
 
Figure 5.5. Spatial properties of FA positions at birth and death.................86 
Figure 5.6. S178A mutation in Paxillin alters adhesion  
assembly and disassembly.............................................................................87 
 
Figure 5.7. The assembly and disassembly phases in S178A  
mutant FAs are significantly longer than those in the wild-type,  
while the stability phase lengths are unaffected............................................88 
 
Figure 5.8. Mutations affecting the interaction of JNK  





LIST OF ABBREVIATIONS 
CAD   Cath.a differentiated 
CALI   Chromophore Assisted Laser Inactivation 
CDC42  Cell division cycle mutant number 42 
CFP   Cyan Fluorescent Protein 
CP   CapZ capping protein 
DRG   Dorsal Root Ganglion 
ECFP   Enhanced Cyan Fluorescent Protein 
EGFP   Enhanced Green Fluorescent Protein 
EYFP   Enhanced Yellow Fluorescent Protein 
FlAsH   Fluorescein Arsenical Hairpin 
GAP   GTPase activating protein 
GDI   Guanine nucleotide dissociation inhibitor 
GDP   Guanosine diphosphate 
GEF   Guanine nucleotide exchange factor 
GTP   Guanosine triphosphate 
KD   Knockdown 
KDR   Knockdown/Rescue 
FA   Focal adhesion 
FALI    Fluorophore Assisted Light Inactivation 
FN3   Fibronectin 10th type III domain 
FP   Fluorescent Protein 
FRAP   Fluorescence Recovery after Photobleaching 
 xiii 
FRET   Förster Resonance Energy Transfer 
JNK   c-Jun N-terminal kinase 
LPA   Lysophosphatidic Acid 
MEF   Mouse embryonic fibroblast 
Mero 53  Merocyanine dye 53 
MERO-CBD  Merocyanine-labeled Cdc42 Binding Domain 
MENA  Mammalian Enabled 
Myr-RFP  Myristolated Red Fluorescent Protein 
NIH 3T3  National Institute of Health; 3-day transfer, inoculum 3 x 105  
PDGF   Platelet Derived Growth Factor 
PTK1   Potorous tridactylus kidney 1 
RBD   Rho binding domain 
ReAsH  Resorufin arsenical hairpin 
RHOA   Ras homolog gene family, member A 
ROS   Reactive Oxygen Species 
SH3   Src Homology 3 domain 
SFK   Src Family Kinase 
SRC   kinase first identified in the Rous Sarcoma virus 
TIR-FM   Total Internal Reflection Fluorescence Microscopy  
YFP   Yellow Fluorescent Protein 
  
CHAPTER 1: Introduction 
Overview 
The complex system of cellular communication consists of a vast array 
components, pathways, and hierarchical networks. These must be precisely regulated for 
a cell to function properly. Many signaling events are localized and transient; in part this 
is how specificity is achieved. To better understand the spatiotemporal component of 
signal transduction, new tools designed specifically to study it must be developed and 
utilized. Subcellular events can be visualized in real-time by high-resolution light 
microscopy. Technological advances in live-cell imaging have offered the means to not 
only observe the phenotypic consequences of signaling events, but to visualize and 
manipulate the activity of their components. This allows for a more complete 
comprehension of how signaling pathways are compartmentalized and temporally 
controlled.  
This dissertation contains three methodologies (Chromophore Assisted Laser 
Inactivation, Biosensors, and Computer Assisted Image Analysis) that utilize live-cell 
microscopy to study spatiotemporal signal transduction. Because the biological scope of 
this thesis is vast, the background of Chromophore Assister Laser Inactivation and 
Biosensors will be introduced in Chapter 1 and the relevant biology for each study will be 
disclosed in the introduction section of its respective chapter.  
 2
Chromophore Assisted Laser Inactivation 
Although analysis of loss of function phenotypes leads to important clues about 
protein function, long-term global protein inactivation via gene knockout or RNA 
interference (RNAi) can lead to compensatory changes at the molecular level that are 
difficult to detect or control. Use of pharmacological inhibitors is limited by a lack of 
subcellular spatial resolution and transport across the plasma membrane. By contrast, 
instantaneous and spatially precise protein inactivation through chromophore-assisted 
laser inactivation (CALI),1, 2 in principle, avoids these issues. In CALI, a photosensitizer 
chromophore is attached to a target protein within a cell. An area of interest is then 
irradiated with an intense beam of light. Absorption of light by the chromophore leads to 
the production of highly reactive free radicals, including reactive oxygen species (ROS) 
that in turn inactivate the proximate target(s). Because the free radical species generated 
during CALI are short-lived, the damage radius has been reported to be limited to 
proteins that are immediately adjacent to the irradiated chromophore.3, 4 Given that 
inactivation can be accomplished within short timescales (often <1 s) and that the 
inactivating light beam can be directed to small regions within a single cell, the technique 









Methods for CALI 
CALI requires that a photosensitizer chromophore is placed immediately adjacent 
to a protein of interest. Over the years there have been several creative strategies to 
achieve light inactivation, with innovations made in both the type of chromophore used 
and how it is directed to its intended target. Here are the methods used to achieve CALI 
to date: 
Malachite green or fluorescein conjugated antibodies. In the original 
demonstrations of CALI by D.G. Jay and colleagues, the dye malachite green was 
conjugated to a target-specific non-function blocking antibody that was microinjected 
into the cell.1, 5-19 This methodology is still being employed today.20, 21 Later malachite 
green was substituted with the fluorescent dye fluorescein, due to its more efficient 
generation of free radical species.22 The use of fluorescein as a photosensitizer also 
prompted a name change to FALI (Fluorophore Assisted Light Inactivation). Though 
effective, this technique never became widely used most likely because it combines the 
Figure 1.1. CALI schematic. Excitation of 
the chromophore with laser light leads to 
production of free radicals, predominantly in 
the form of reactive oxygen species (ROS). 
ROS are highly destructive, immediately 
damaging the protein and destroying the 
chromophore. However, the short half-life of 
ROS keeps the destruction radius to just a 
few nanometers and only the protein directly 
adjacent to the chromophore is effected. 
Combined with the ability to direct light 
anywhere within the cell, CALI has the 
potential for local and instantaneous loss of 
function.   
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need to microinject live cells and requires a reagent that is not available for most targets 
(non-function blocking antibody).  
 
FlAsH and ReAsH. More recently, methodologies have been described using 
membrane-permeable fluorescent ligands that bind to genetically encoded target 
sequences. These strategies vastly expand the pool of potential CALI targets, as non-
function-blocking antibodies that are specific for a single target are fairly rare. They also 
avoid having to use microinjection for cytoplasmic targets. The first method uses the 
biarsenical dyes ReAsH (resorufin-based arsenical hairpin binder)23 and FlAsH 
(fluorescein-based arsenical hairpin binder).24 ReAsH and FlAsH have an intrinsic high-
affinity interaction with the tetracysteine motif Cys-Cys-Pro-Gly-Cys-Cys (Kd in the pM 
or lower range). ReAsH-based CALI was used to inactivate connexin 43 that was 
expressed as a tetracysteine fusion, and loss-of-function was monitored 
electrophysiologically by the decrease in intracellular coupling mediated by gap 
junctions.25 FlAsH was demonstrated to label synaptogamin-I into which the tetracysteine 
motif was engineered and expressed in synaptogamin-I null Drosophila mutants. CALI of 
dissected larvae that had been labeled with FlAsH impaired neurotransmitter release from 
the neuromuscular junction by interfering with the synaptic vesicle post-docking fusion 
mechanism.26 
 
FK-FALI. An alternative targeting strategy was subsequently developed that 
exploited the high-affinity interaction between FKBP12 (F36V), a protein that binds to 
the natural ligand FK506, and its synthetic ligand for FKBP12 (SLF′) (Kd 10 pM).27 In 
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this methodology, the protein target is expressed as a fusion with FKB12 and the cell is 
incubated with fluorescein-labeled SLF′. SLF is membrane permeable and thus avoids the 
need to microinject any reagents. It was demonstrated that CALI of fluorescein-labeled 
SLF′ targeted to β-galactosidase could inactivate this enzyme both in vitro and when 
expressed in fibroblasts. 
 
Environment-sensitive photosensitizers. To reduce off-target effects of non-
specific labeling, compounds termed Environment-sensitive photosensitizers (ESPers) 
have been developed that consist of a CALI chromophore, a targeting ligand and a 
polarity-sensitive electron-donor moiety, all covalently conjugated.28 The electron donor 
quenches singlet-oxygen production by the excited CALI-chromophore in aqueous 
environments; however, when this new class of CALI reagent is bound to a hydrophobic 
environment of a target receptor, singlet-oxygen generation occurs and inactivates the 
receptor. Using this new strategy, the inactivation of the inositol (1,4,5)-trisphosphate 
[Ins(1,4,5)P3] receptor in DT40 cells was demonstrated by monitoring the inhibition of 
calcium release from the endoplasmic reticulum (ER) into the cytoplasm upon 
Ins(1,4,5)P3 stimulation. 
 
Suicide enzyme systems. Recent development of protein tags that form a 
covalent bond with their ligands has expanded the repertoire of in vivo protein labeling. 
These include HaloTag® and Snap-tag labeling systems: the former utilizes a hydrolase, 
the latter an alkylase. These genetically-encoded small enzymes are translationally added 
to the target protein and form covalent attachments at their active sites to their respective 
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ligands, preventing reaction with additional substrates. For both systems, membrane-
permeable fluorescently labeled substrate reagents are commercially available. 
Additionally, both the enzyme dependent linkage of labeling agent to target protein and 
the subsequent stable structures that are formed decrease the risk of non-specific labeling. 
HaloTag® CALI has been demonstrated but only in vitro,29 while CALI of fluorescein 
labeled α nd γ-tubulin SNAP-tag fusions has been demonstrated in living cells.30  
 
Genetically encoded fluorescent protein fusions. There is only one CALI 
methodology which obviates the need to add any exogenous labeling agents, and that is 
using fluorescent protein fusions. In both single photon and multiphoton excitation 
applications, enhanced green fluorescent protein (EGFP), a widely used fluorescent 
protein, has been shown to be an effective CALI chromophore. Using cells expressing 
EGFP-α-actinin, CALI was employed to demonstrate that α-actinin provides a 
mechanical link between stress fibers and focal adhesions.31 Furthermore, EGFP-
connexin 43 expressed in HeLa cells could be inactivated by two-photon excitation with 
the result that electrical coupling between cells was abrogated.32 The same study also 
showed that two-photon CALI of EGFP-Aurora B disrupts mitosis; Aurora B is a kinase 
essential for mitosis.  
Although many fluorescent proteins are weak singlet-oxygen producers, an 
efficient genetically encoded ROS generator, Killer Red,33 results in cell lethality at high 
illumination doses; at lower doses, killer red fusions with pleckstrin homology domains 
leads to dissociation of the domain from the plasma membrane, indicating specific CALI 
action. Recent structural analysis has determined that the ability of Killer Red to act as a 
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super-photosensitizing FP lies within a water channel that connects the chromophore to 
the environment, allowing a more unrestricted transport of oxygen into and ROS out of 
the FP β-barrel.34  
 
Mechanism of Inactivation by CALI 
Overall, several different molecules have been shown to be adequate CALI 
reagents, as assessed by the production of distinct loss-of-function phenotypes. These 
results beg the question of how the selective inactivation occurs. CALI-induced 
photodamage is photodynamic, meaning that, in addition to the CALI reagent acting as a 
photosensitizer, the process involves light and oxygen. In CALI target proteins are 
inactivated by ROS. These are generated when chromophores that have become excited 
through light absorption react with oxygen in the environment. The toxicity of ROS is a 
consequence of their ability to oxidize proteins, lipids, DNA and carbohydrates.35 In most 
cases, the predominant ROS causing CALI is thought to be singlet oxygen (102).22, 25, 36 
Though evidence does exist that CALI can be mediated by other ROS in the case of 
malachite green (OH radicals)4 and Killer Red (superoxide anions in addition to 102).33  
Once 102 (and other ROS) is produced, it can either react with cellular targets 
including proteins, nucleic acids and lipids, or be physically quenched by reaction with 
other compounds in the cellular environment. The reactions with proteins predominate 
and are of immediate interest for CALI. 102 can oxidize side chains of amino acid 
residues including histidine, tyrosine, tryptophan, methionine and cysteine, leading to 
both intramolecular and protein–protein cross-linking and aggregation, loss of enzyme 
and other functional activities.37, 38 The most detailed information to date regarding the 
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mechanism of CALI inactivation was obtained by Yan et al.36, who showed that oxidative 
photodamage to illuminated FlAsH-labeled calmodulin results in sulfoxide formation on 
surface methionine residues, which disrupts the binding interface between calmodulin 
and its partners. No dependence on the distance between FlAsH and particular 
methionines was found, indicating that reaction with rather than diffusion of 102 was rate-
limiting. In addition, reactive histidine intermediates were formed, leading to potential 
cross-linking to binding partners.36 Crosslinking as also been shown subsequent to in 
vitro EGFP-CALI of glutathione-S-transferase.39  
 
Caveats of CALI Methods 
Successful inactivation of a target protein through CALI depends upon two 
principal factors: the effectiveness of the chromophore in generating ROS and the 
reliability of chromophore targeting. It is only when these two factors fruitfully combine 
that CALI can occur without causing artifacts due to collateral damage. Every 
methodology involves a trade-off between these two characteristics.  
With regards to photosensitization, it is clear that non-specific photodamage can 
be caused through the absorption of visible light by the cellular environment; the more 
light used to achieve CALI, the greater the risk. Small molecule dyes of the xanthene 
family are much better photosensitizers than fluorescent proteins.40, 41 It can be presumed 
that because fluorescent proteins (FPs) appear in organisms exposed to sunlight, 
evolution would require that FPs do not produce abundant ROS upon illumination.42 
With GFP and all other fluorescent proteins, the chromophore is surrounded by a β-can 
structure of the protein with ‘lids’ at either end.43 This physically hinders interaction 
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between the chromophore and molecular oxygen, the source for singlet-oxygen 
production. Additionally it prevents release of reactive oxygen products once produced. 
Presumably this is the reason that it takes much more light (orders of magnitude) to 
produce a demonstrable CALI effect when EGFP, rather than small organic dyes, is 
employed as a chromophore.41  
The super-photosensitizing FP Killer Red subverts the β-can structure through the 
introduction of a water channel that allows for a less restricted passage of oxygen and its 
reactive products,34 thus requiring less light for CALI to occur. However, Killer Red is 
currently an obligate dimer and may not be suitable for labeling all targets. Additionally, 
it has a partially mature green intermediate state that is photoresistant until it is 
photobleached.34 This requires a pre-bleaching period for Killer Red to reach its full 
CALI potential.  
There also may be such a thing as photosensitizer that is too effective, expanding 
the damage radius beyond specificity. This question was addressed for fluorescein-CALI 
and researchers provided compelling evidence by using sensitive transport assays that the 
inactivation radius for fluorescein extends beyond its immediate target.44 CALI of a 
glutamine receptor that modulates N-type calcium channels in neurons was performed. 
The receptor was modified so that it could be labeled with fluorescein α-bungarotoxin. It 
was found that CALI significantly affected calcium transport modulated by a glutamate 
receptor, as expected. However, if the α-bungarotoxin site was engineered into other 
unrelated transporters, modulation of N-type calcium channels was also reduced. 
Moreover, even voltage-dependent but receptor-independent modulation of N-type 
calcium transport could be disrupted by CALI of a non-GPCR labeled with fluorescein α-
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bungarotoxin. Other evidence of non-specific damage from fluorescien includes CALI of 
labeled antibodies to the Ki-67 nuclear protein which caused it to be crosslinked to its 
upstream binding factor.45 
Secondly, and of equal importance as chromophore selection, is the targeting 
method used for directing the chromophore to the protein of interest. If there is any 
residual chromophore present in the cell after labeling or if it is non-specifically attached 
to something other than the target then there is a strong chance of collateral damage 
during irradiation, even with the lower light doses that can be used for strong 
photosensitizers. Such a risk is incurred by the methodologies that rely on exogenously 
added labeling reagents that require the washing out of excess unbound chromophore. 
Non-transfected cell lines that exhibit background staining after incubation with the 
labeling reagent cannot be used. Dyes such as FlAsH and ReAsH and their antidotes can 
produce non-specific labeling and resultant toxicity.46, 47 Specificity can also be 
problematic when the FKBP12 (F36V) mutant is fused to target proteins; although it is 
not supposed to be recognized any known proteins except the synthetic ligand conjugated 
to fluorescein (FL-SLF′), cells incubated with this ligand exhibited appreciable non-
specific inactivation.27  
 
Summary 
As described above, every CALI strategy has its own trade-offs involving choice 
of chromophore and targeting method. ReAsH-CALI requires minimal light but has a 
large risk of off-target labeling while EGFP-CALI requires the most light but eliminates 
the risk of collateral damage due to non-specific labeling. What is clear is that any further 
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validation of or modification to the above techniques that increases their effectiveness 
will allow more researchers to utilize these valuable tools to inactivate their protein of 
choice with spatial and temporal precision.  Chapter 2 of this dissertation provides a 
study about validating and increasing the effectiveness of EGFP-CALI.  
 
Biosensors 
 Signaling for most cellular process is localized and transient. To better understand 
how these signals are regulated in space and time, probes need to be developed that not 
only report the localization about a molecule of interest, and also provide information 
about its activation state. While some signaling proteins become discretely localized as 
they assert function, many are broadly distributed and it is only their regulated activity 
that is spatially discrete (Figure 1.2). For these proteins, biosensors can be used to study 
their function. Biosensors are fluorescent indicators of activation and are designed for use 
in high-resolution imaging applications. They offer a living window into the signaling 
mechanisms of a cell and can yield information about transduction pathways that is not 
obtainable through conventional methods.  
 
Biosensor Strategy  
Biosensors for protein activation consist of two core components: an affinity 
reagent and a fluorescent binding reporter. The affinity reagent provides the means to 
localize a specific target within a cell while the binding reporter provides a unique signal 
that quantifies this interaction (Figure 1.3). The affinity reagent detects activation of a 
protein either through binding selectively to its activated confirmation or by recognizing 
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a molecule formed by the activated target (i.e. a phosphorylated kinase substrate or a lipid 
synthesized by the activated enzyme). The binding of the affinity reagent then leads to a 
change in fluorescence of the binding reporter via one of several mechanisms: simple 
accumulation of fluorescent affinity reagent near activated targets, effects on Förster 
resonance energy transfer (FRET), or fluorescence of environmentally sensitive dyes.  
Many creative combinations of affinity reagent and binding reporter have been 
developed. The design of a biosensor can have profound effects both on its capability to 
detect signaling events and its performance in living cells. Different designs encompass a 
spectrum of trade-offs between specificity, sensitivity, cell perturbation, and difficulty of 
use. These design strategies and their pros and cons are discussed below. For the purpose 
of this introduction, only biosensors that can detect protein activation and be used in 
living cells will be discussed.  
Rac localization Rac activation
Figure 1.2. Localization vs. activation of signaling proteins. The images above 
show a fibroblast that is migrating in the direction of the red arrow. Psuedocoloring is 
used to display fluorescent intensity, with warm colors indicating high intensity. A 
biosensor for the GTPase Rac is used to distinguish between its localization (left 
panel) and activation (right panel). Rac is localized diffusely (the increase of intensity 
around and in the nucleus are due to volume changes in the cell) but is activated in a 
spatially discrete manner at the front of the migrating cell.65  
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Biosensor Designs 
Tagged Domains. There are occasions when an affinity reagent for an activated 
protein or its modified substrate is robustly localized within the cell. For these cases it 
may be sufficient to simply label the affinity reagent with a fluorescent protein or dye and 
observe its subcellular translocation. The two most prevalent adaptations of this concept 
have used either phosphoinositide-binding pleckstrin homology domains or phosphor-
tyrosine binding SH2 domains labeled with a fluorescent protein variant. Using this 
approach researchers have demonstrated: the redistribution of both phosphatidylinositol 
4,5-bisphosphate48 and tyrosine phosphorylation49 downstream of cell surface receptor 
activation; the accumulation of phosphatidylinositol-3,4,-trisphosphate and 
phosphatidylinositol-3,4,5-trisphosphate at the front of chemotaxing Dictyostelium;50, 51 
tyrosine phosphorylation within individual focal adhesions of migrating cells;52-55 and 
Src-dependent tyrosine phosphorylation at the tips of growth cone filopodia56 among 
numerous other studies. Of note is that though this technique is the easiest to implement, 
it is also the least sensitive, requiring substantial localization increases over background 
to visualize discreet signals. It is also most prone to specificity artifacts if the affinity 
reagent is at all promiscuous. Furthermore, there are many examples in cell signaling 
where localization of an activated protein or the byproduct its activity cannot be 
discretely localized (Figure 1.2). For these cases more sophisticated means of reporting 
binding interactions must be used.  
 
Fluorescence Resonance Energy Transfer. When the binding interactions 
between an affinity reagent and its target are not robust, one case use Fluorescence 
 14
Resonance Energy Transfer (FRET). A fluorescent molecule is excited by light at one 
wavelength and emits light at a higher, lower energy wavelength. If this fluorophore is 
paired with a second fluorescent molecule that so that the emission wavelength of one 
(donor) overlaps with the excitation wavelength of the other (acceptor), excitation of the 
donor will result in an energy transfer to and excitation of the acceptor if the two 
fluorophores are within 60-80 Å of each other.57, 58 The efficiency of this reaction is 
extremely distance sensitive, determined by the inverse sixth power of the distance 
between donor and acceptor.59 FRET is fast, reversible and quantifiable and can thus be 
used to visualize and measure the interaction between two components with great 
sensitivity. Affinity reagent specificity is “enhanced” as only interactions with the labeled 
target will be reported. The caveat of FRET is that it requires numerous processing steps 
of the raw images to generate the final result.60, 61 If this is not done with great care, or if 
the optical configuration of the microscope is problematic, then it is easily possible to 
generate false positive or negative FRET signals. FRET biosensors come in two different 
variations: dual-chain and single chain, which are discussed below.  
Dual Chain FRET. When two proteins or a protein and an affinity reagent form a 
direct interaction, dual-chain FRET can occur if one of the partners is labeled with a 
donor fluorophore and the other an acceptor. FRET is commonly achieved between two 
fluorescent proteins because of the ease of genetically encoded expression; one of the 
catalysts for mutating GFP after its discovery was to produce color variations that could 
undergo FRET.62 In recent years there have been numerous advances in fluorescent 
protein biology that have produced excellent FRET pairs.63 However, FRET between a 
dye and a FP,64-66 or between two dyes has also been performed.67-69  A point-in-case of 
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this is the biosensor for the GTPase Rac, developed by Klaus Hahn and collegues.65 The 
original configuration of the biosensor consisted of Rac labeled with the FRET donor 
GFP. This portion of the biosensor was genetically encoded. Then an activity-specific 
binding domain of a Rac effector (PBD) was labeled with the acceptor fluorescent dye 
Alexa 546. This portion of the biosensor was produced in vitro and microinjected into the 
cell. This biosensor was used to show Rac activation in migrating cells (see Figure1.2 for 
an example), 65, 70, 71 and in response to integrin regulation71, 72 and mechanical tension.73 
Subsequently, the same affinity reagent and target where tagged with the genetically 
encoded fluorescent protein FRET pair (the CFP and YFP variants CyPet and YPet) to 
produce a biosensor that was entirely genetically encoded with very large dynamic 
range.74 The Rac indicator is only one of numerous other dual-chain sensors have been 
produced.66, 68, 69, 75-78  
Dual-chain FRET requires the most intensive calibrations and image-processing 
steps.61, 79 For example, coefficients for direct acceptor excitation and donor bleedthrough 
must be calculated and used when quantifying FRET; these should be calibrated with 
every experiment. Further, variable expression levels of donor and acceptor molecules 
can change the apparent FRET efficiency. These should be kept as constant as possible, 
with an ideal 1:1 ratio between donor and acceptor. 61 It is difficult to achieve 
unimolecular concentrations if the two components must be introduced separately. This is 
also true at the subcellular level- a loss of FRET will be registered if one of the 
fluorophores is excluded from a particular compartment.72  
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Single Chain FRET. FRET partners can also be engineered into a single 
molecule which undergoes a conformational change upon activation. This can occur if 
the fluorophores are integrated in such a way that that their FRET efficiency changes 
either through distance or dipole orientation in response a conformational shift of the 
protein(s) they are attached to. The single-chain approach overcomes the stoichiometry 
issues associated with dual-chain FRET, guaranteeing a unimolecular concentration and 
equal subcellular distribution of the two fluorophores. Also, FRET can simply be 
calculated by exciting the donor and measuring the ratio between the acceptor and donor 
emissions.79 Finally, nearly all of the single-chain biosensors made to date have been 
genetically encoded and are thus easily introduced into cells. All of these features have 
combined to make single-chain FRET biosensors more widely accessible to biologists 
than their dual-chain counterparts.  
 The principal drawback of the single-chain design is the difficulty of orienting the 
FRET partners on the same molecule so that they undergo a significant FRET shift when 
the molecule changes conformation. Not every protein undergoes a substantial structural 
change as it switches between active and inactive states or as it interacts with binding 
partners. In order to enhance the conformational shift of a single-chain sensor, a popular 
design has been implemented consisting of the two FRET partners, the target protein, and 
an affinity reagent that binds the target in an activity specific manner. Each of these is 
separated by a flexible protein linker; the order of components, linker lengths, and 
affinity reagent can be all be changed to enhance the maximum FRET response.80, 81 This 
strategy has been used successfully for GTPases, kinases and others (reviewed in 81). 
However, even when a significant FRET response can be achieved, it is usually on the 
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order of 30-60% total change from the inactive to active state of the biosensor. This is 
vastly reduced from the potential dynamic range of intermolecular FP FRET, which can 
exceed changes of 20-fold.74 This is most likely due to the constrained movement of the 
two fluorophores that are covalently linked, preventing them from reaching the upper and 
lower limits of their FRET potential. Thus with single-chain biosensors sensitivity is 
sacrificed for ease of expression and calculation of FRET.  
 
Environment-sensitive fluorophores. An alternate approach to reporting binding 
interactions is to use fluorescent dyes that change their emission in response to their 
surrounding environment. Many environmentally sensitive dyes have been developed, 
but few of these have had any applications in living cells. Recently a new class of bright, 
photostable, water-soluble, solvatochromic merocyanine dyes suitable for live-cell 
imaging was developed by A. Toutchkine and colleagues.82 The quantum yield of these 
merocyanine derivatives is highly related to the polarity of the solvent they are in. This 
means that in a cellular environment, they will alter their fluorescence intensity as they 
move from being exposed to the cytoplasm to being pressed against a hydrophobic 
Figure 1.3. Biosensor schematic. Illustrated 
here is Mero-CBD, a biosensor for the 
GTPase Cdc42.83 In this biosensors design, a 
domain of the protein WASP that only 
interacts with the active confirmation of 
Cdc42 serves as the affinity reagent. The 
binding reporter is an environmentally-
sensitive fluorescent dye. When the affinity 
reagent interacts with active Cdc42, the dye 
increases its fluorescence intensity. This is 
measured quantitatively in cells by dividing 
the intensity of the dye’s emission by that of 
the environment-insensitive EGFP.    
 
 18
portion of a target protein. One of these dyes was incorporated onto a fragment of the 
protein N-WASP that only interacts with the active form of the GTPase Cdc42 to 
generate a biosensor for endogenous Cdc42 activation (Mero-CBD).83 This biosensor 
exhibited a four-fold change in intensity when the probe was bound to active Cdc42, 
providing a large dynamic range for sensitive measurements. Mero-CBD has been used 
to show Cdc42 activation kinetics during cell migration, and to visualize Cdc42 activity 
in filopodia, the Golgi, and downstream of microtubules.83-85 Feasibly, this dye or others 
like it could be attached to affinity reagents for other targets, vastly expanding the suite of 
tools available to visualize the activation kinetics of endogenous targets.  
 With domain-based biosensors using an intensity changing fluorescent dye, a 
second non-responsive fluorophore has to be added to the sensor design to account for 
intensity changes resulting from volume fluctuations or accumulation of the probe within 
the cell. Thus, ratio-imaging must be used. Additionally, these dyes do not exhibit the 
same stability in cells as fluorescent proteins and are not suitable for long-term 
experiments of more than a few hours.86 Finally, there is currently no suitable method for 
introducing protein-based biosensors into cells for imaging purposes so these probes must 
be microinjected.  
 
Affinity Reagents 
 Affinity reagents are a critical component to biosensor design. By selectively 
binding activated targets in cells, they provide the means for sensing conformational 
changes. Signaling pathway specificity is mediated by the discriminating interactions 
between its components.87 Some of these interactions occur through effector binding 
 19
regions that are selective only for the active form of their binding partner or for a specific 
byproduct of a signaling event. To date these domains, isolated from the proteins from 
which they belong, have been the source for affinity reagents used to make biosensors.  
 A potential problem from using these affinity reagents is that can inhibit 
downstream signaling by occupying effector positions, preventing the real effectors from 
binding the target. For example, the affinity reagent used for a dual-chain biosensor for 
the GTPase Rac is the p21 binding domain (PBD) from p21-activated kinase. Expression 
of this domain alone sequesters the GTPase and prevents native effector binding.88 When 
used as a biosensor, it is imperative to express it at tracer amounts so that it does not 
inhibit the signaling events it is trying to detect. Researches who developed the biosensor 
determined a concentration that could be microinjected into cells that did not inhibit Rac-
dependent processes.65  This issue is most compounded when the affinity reagent is used 
in a tagged domain or environmentally-sensitive dye based biosensor format. When used 
for dual-chain FRET, there is additional target that is introduced into the cell which may 
dampen its inhibition of endogenous processes. An affinity reagent is least likely to 
perturb in the single-chain format, as it will presumptively only bind to the target to 
which it is covalently linked.89 
 The second issue with affinity reagents is that they do not exist for many targets. 
Biosensor engineers are limited to what nature has provided. Even those that exhibit 
excellent selectivity for the active confirmation of their target may have specificity 
issues. Once again using PBD of p21-activated kinase as an example, this affinity reagent 
binds not only to Rac but also to the active confirmation of the similar GTPase Cdc42.88 
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Specificity of this probe is only achieved through FRET with its target. This is how the 
same affinity reagent has been used as a biosensor for two different targets.65, 66 To sense 
endogenous Cdc42 activation with an environmentally-sensitive dye probe, a different 
affinity domain had to be used.83 What the biosensor field needs is a way to generate 
selective and specific binders on a made-to-order basis. It would also be beneficial if 
these binders recognized the active form of its target without inhibiting its activity or 
native behavior.  
Summary 
Biosensors represent a powerful set of tools that can be used to visualize and 
quantify spatiotemporal signaling events. Every biosensor design has its advantages and 
limitations; these must be carefully balanced to generate a successful probe. There are 
two directives that drive the biosensor field. The first is the generation of new probes, 
either by exploiting existing methodologies or inventing new ones. Chapter 3 of this 
dissertation will discuss a study regarding the creation of a new biosensor for endogenous 
Src-family kinase activation based on an artificial affinity reagent that was generated by 
screening a library of potential biosensor scaffolds. Secondly, biosensors are validated by 
their subsequent use to generate exciting new biological results. Many probes are made as 
a proof of concept and then never revisited; the ones that find their way into additional 
studies are testaments that this approach really does work. Chapter 4 of this dissertation 
will discuss the use of a single-chain FRET biosensor for the GTPase RhoA to 
demonstrate novel spatiotemporal RhoA signaling in differentiating neurons.  
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Chromophore Assisted Laser Inactivation (CALI) is a light-mediated technique that 
offers precise spatiotemporal control of protein inactivation, enabling better 
understanding of the protein’s role in cell function.  Enhanced Green Fluorescent Protein 
(EGFP) has been used effectively as a CALI chromophore and its co-translational 
attachment to the target protein avoids having to use exogenously added labeling 
reagents. A potential drawback to EGFP-CALI is that the CALI phenotype can be 
obscured by the endogenous, unlabeled protein that is not susceptible to light 
inactivation. Performing EGFP-CALI experiments in deficient cells rescued with 
functional EGFP-fusion proteins permits more complete loss of function to be achieved. 
Here we present a novel lentiviral system for rapid and efficient generation of 
knockdown cell lines complemented with physiological levels of EGFP-fusion proteins. 
We demonstrate that CALI of EGFP-CapZβ increases uncapped actin filaments, resulting 
in enhanced filament growth and the formation of numerous protrusive structures. We 
show that these effects are completely dependent upon knocking down the endogenous 
protein. We also demonstrate that CALI of EGFP-Mena in Mena/VASP deficient cells 





Analysis of loss of function phenotypes often leads to critical insights about 
protein function. However, long-term global protein inactivation via gene knockout or 
RNAi can lead to compensatory changes at the molecular level that are difficult to detect 
or control. Chromophore Assisted Laser Inactivation (CALI) circumvents these issues 
through instantaneous and spatially precise protein inactivation.1 With CALI, target 
proteins are inactivated by reactive photoproducts such as reactive oxygen species (ROS) 
that are generated by intense irradiation of photosensitizer chromophores.15 The short 
half-life of these ROS ensures that only proteins immediately adjacent to the 
chromophore are affected.3 CALI has been used to inactivate varied protein targets, but 
some skepticism remains about the specificity of this approach and its general 
applicability.  
 CALI specificity is achieved by selectively labeling the target protein with a 
chromophore. This was originally done by microinjecting non-function blocking 
antibodies labeled with malachite green or fluorescein into cells2, a methodology that has 
proven to be technically difficult and has only been used by a limited number of 
laboratories. More recently CALI strategies have been developed that utilize membrane 
permeable chromophore components that recognize genetically encoded tags. These 
include the biarsenical dyes FlAsH26, 90 and ReAsh25 which specifically recognize 12 
amino acid tetracystine motifs, and a fluorescein-conjugated ligand (SLF’) whose 
intracellular target protein is FKBP12(F36V) .27 These membrane permeable labeling 
strategies have increased the potential utility of CALI, but still suffer from having to use 
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exogenously added reagents which introduces the risk of non-specific labeling and 
collateral photodamage during irradiation.25, 44   
A third CALI approach is to use fluorescent proteins as photosensitizers. CALI 
using fluorescent protein fusions offers the unique advantage of having a CALI system in 
which all of the components are genetically encoded, thereby avoiding having to label the 
protein of interest with exogenous reagents. Co-translational attachment of the 
fluorescent protein to its target provides the highest possible degree of specificity. EGFP 
is a widely used fluorescent protein that has been previously shown to be an effective 
CALI chromophore with both single photon31 and multiphoton excitation32. While EGFP 
has many advantages for studies of protein localization, the drawback to using this 
fluorescent protein as a CALI chromophore is that it is a relatively poor photosensitizer. 
This must be compensated for by using irradiation doses that are substantially higher than 
what is needed for inactivation by fluorescein, FlAsH, or ReAsH.41 Any changes in the 
experimental procedure of EGFP-CALI that improves its efficacy would allow more 
researchers to use this technique to locally and acutely inactivate proteins using CALI 
while retaining the benefits of EGFP as a localization tool.  
One such improvement would be to perform CALI experiments in cells where the 
only functional version of the protein is EGFP-labeled.  The presence of endogenous, 
unlabeled protein that is resistant to light inactivation has the potential to compensate for 
the loss of EGFP-tagged proteins, and can therefore mask the CALI effect. To address 
this problem one can use cells that are deficient for the endogenous protein and rescued 
with the EGFP-fusion complement.  To facilitate production of complemented cell lines, 
we present a novel system where knockdown of endogenous protein and rescue with an 
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EGFP-fusion protein can be accomplished in a single step.  We demonstrate the CALI of 
EGFP-Capping protein (CP) in rescued deficient cells and show that knockdown of the 
endogenous protein is essential for CP loss of function following laser irradiation.  As a 
second example of this approach, we also demonstrate the CALI of EGFP-Mena in 
rescued fibroblasts derived from Mena-/-VASP-/- mice. 
Capping protein and Mena both localize to the barbed ends of actin filaments 
where they either negatively or positively regulate filament elongation; antagonism 
between the two factors governs the supramolecular organization of actin filaments in 
motile cells and has a profound effect on motility and migration.91-98With EGFP-CALI, 
we recapitulate the loss-of-function phenotypes of Capping protein and Mena reported 
previously: CALI of capping protein creates a local increase in barbed ends and F-actin 
resulting in numerous protrusive structures,99 while CALI of Mena induces larger and 
more stable lamellipodial protrusions.95 CALI of CP and Mena cause distinct changes in 
local subcellular structure despite the overlapping localization of both proteins at the 
leading edge. In both cases, the phenotypic changes that occur upon CALI are positive 
(eg. the generation of a new structure), strongly suggesting that CALI is leading to highly 
specific protein inactivation under these conditions.     
 
Results 
A lentivirus system for single-step generation of deficient cells complemented with 
EGFP-fusion proteins. In order to rapidly generate knockdown cells rescued with a 
functional EGFP-fusion protein, we modified a lentiviral vector to concomitantly express 
an shRNA from the PolIII U6 promoter and a functional EGFP-fusion protein from the 5’ 
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LTR promoter of the Murine Stem Cell Virus (MSCV) (Fig. 2.1A). The LTR promoter 
drives modest expression levels,93 a detail that is important if a physiological level of the 
rescue protein is desired. This simultaneous knockdown/rescue system requires the 
complementing EGFP-fusion protein to be resistant to the RNAi due to mismatches in the 
RNAi target sequence. This system allows the production of deficient cells rescued with 
EGFP-fusions without having to generate a knockout mouse or having to perform 
multiple transfections with siRNA oligonucleotides and/or expression vectors. An 
additional advantage of simultaneous knockdown/rescue is that knockdown occurs in the 
presence of a functional copy of the knocked down gene, reducing the risk of coordinate 
regulatory and compensatory changes as the endogenous protein is lost.  
Capping protein (CapZ, abbreviated CP throughout) is an obligate heterodimer of alpha 
and beta subunits and is the predominant actin filament capping protein in most cells.100 
To create a knockdown/rescue vector for CP, we utilized an shRNA that specifically 
targets rat CapZβ and an RNAi-resistant EGFP-human CapZβ (hereafter referred to as 
EGFP-CP) fusion. The phenotypic effects of CP knockdown using this shRNA sequence 
have been previously characterized and serve as a useful point of comparison for our 
studies.99 The loss of CP has dramatic effects on the actin cytoskeleton, most notably a 
substantial increase in filopodia. We confirmed this phenotype by infecting Rat2 
fibroblasts with a version of the lentiviral vector that expresses only the knockdown 
shRNA, but not the rescue component (Fig. 2.1B, middle panel). In addition to increased 
filopodia, we also observed a large increase of ruffling in these cells (data not shown). 
Both of these effects are consistent with loss of CP activity and the subsequent increase 
in uncapped and rapidly growing actin filaments. 
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  We infected Rat2 fibroblasts with the CP knockdown/rescue lentivirus and 
identified a clonal derivative with no detectable expression of endogenous CPβ that was 
complemented with a physiological level of EGFP-CP (Fig 2.1C). This 
knockdown/rescue cell line was phenotypically indistinguishable from the control Rat2 
cells (Fig. 2.1B, top and bottom panels), indicating that the EGFP-CP functionally 
complemented the shRNA-induced phenotype. This is consistent with data showing that 
Xenopus CPβ tagged with EGFP at the same terminus is functional and has similar on-
rate and dissociation constants to actin barbed ends as unlabeled CP.101 
 
CALI of EGFP-CP acutely induces the formation of dorsal protrusions in deficient 
cells, but not in cells retaining endogenous CP expression. We performed CALI of 
EGFP-CP in both knockdown/rescue (KDR) cells and cells which expressed EGFP-CP 
without knockdown of the endogenous gene. In both cell lines, EGFP-CP was expressed 
a comparable levels (data not shown). Cells were irradiated with light from the 488nm 
Figure 2.1. A lentiviral system for 
simultaneous knockdown and 
rescue with a functional EGFP-
fusion complement.  (A) Schematic 
of the lentiviral expression vector 
used for simultaneous knockdown of 
rat CPβ (rCPβ) and rescue with 
EGFP-human CPβ (EGFP-hCPβ), 
open triangles represent LoxP sites. 
(B) DIC images of a wild-tpe Rat2 
fibroblast (top panel) and Rat2 
fibroblasts infected with only the 
knockdown portion of the vector 
(middle panels) or the complete 
knockdown/rescue construct 
(bottom panel), scale bar is 20µm. 
(C) Western blot of wild-type Rat2 
fibroblasts (left lane) and a clonally 
derived Rat2 cell line infected with 
the knockdown/rescue vector.  
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line of an argon ion laser focused on the specimen plane with a beam diameter of about 
23µm (approximately 1/4 to 1/6 of total cell area; Fig. 2A, white circle). After 
administration of 100ms dose of 1.5 mW/µm2 laser light, KDR cells exhibited dynamic 
changes on the dorsal surface of the cell, forming numerous protrusions (Fig. 2.2A and 
B). However, in contrast to the filopodia phenotype that is seen with long-term CP 
depletion (Fig. 2.1B, middle panel) many of these structures most strongly resembled 
intrapodia, actin-based protrusions that occur on the dorsal surface of migrating growth 
cones.102, 103 The difference may represent the effects of long-term vs. instantaneous loss 
of CP. The formation and curvilinear extension of these protrusions was exclusive to the 
area that was irradiated (Fig. 2.2A). When these cells were irradiated with a smaller beam 
size (5µm; 6.1 mW/µm2), no change in the dorsal surface was apparent (data not shown), 
despite the increase in photon flux. These data are qualitatively consistent with the rapid 
fluorescence recovery after photobleaching kinetics for EGFP-CP (Table 2.1: note that 
diffusional recovery would scale as bleached region diameter squared and substantial 
recovery would therefore only occur after approximately 150s, a time in agreement with 
when the phenotype begins to reverse as seen in Figure 2D) and suggest that the CP 
CALI effects require inactivating a large enough fraction of the EGFP-CP pool to avoid 
rapid compensation from intact, non-irradiated EGFP-CP diffusing in from surrounding 
areas.  
When cells expressing EGFP-CP without knockdown of endogenous CPβ were 
irradiated with the full light dose, no detectable effect was observed (Fig. 2.2B), 
indicating that the unlabeled endogenous CP in these cells is resistant to CALI and 
completely masks the effect of EGFP-CP inactivation. As an additional control, we 
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irradiated Rat2 cells expressing soluble EGFP to test for nonspecific laser-induced effects 
and again observed no morphological change in the irradiated area.  
 
Figure 2.2. CALI of EGFP-CP induces the formation of dorsal ruffles and 
filopodia only in the knockdown/rescue background. (A) DIC images of Rat2 
EGFP-CP knockdown/rescue (KDR) cell line before and three minutes after CALI 
of EGFP-CP (left panels) and fluorescent images of EGFP-CP before and 
immediately after CALI (right panels), area of irradiation is indicated with a black 
circle, scale bar is 20µm. (B) Time-lapse images of the irradiated regions of EGFP-
CP KDR cells (top panels) and cells expressing EGFP-CP without knockdown of 
endogenous CP (EGFP-CP no KD, bottom panels) before and after CALI, scale bar 
is 10µm. (C) DIC images (left panels) and Sobel filtered binary images (right panels, 
for details see Methods) before (top panels) and two minutes after (bottom panels) 
CALI. The white circle represents the 12µm diameter center of the irradiated area 
that was used to measure the local edge detection index. Raw edge index values are 
shown next to their respective images. (D) Plot showing the normalized edge 
detection values in the irradiated region over time for EGFP-CP KDR cells (n = 20), 
EGFP-CP no KD cells (n = 8), and cells expressing EGFP (n = 12), the break in 
each line represents when the movies were paused to perform laser irradiation, error 
bars are s.e.m. 
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To objectively quantify the magnitude of the morphological effect induced by 
CALI, we analyzed the DIC time-lapse images with an edge detection method (see 
Methods for details). Application of a Sobel edge detection kernel to DIC images resulted 
in increased edge detection in regions that contained dorsal structures (Fig. 2.2C). A 
normalized index of these structures was generated and plotted against time to display the 
kinetics of this event (Fig. 2.2D). CALI of EGFP-CP in KDR cells resulted in an 
immediate increase in dorsal structures that peaked at approximately 80s after irradiation. 
This activity then gradually declined (Fig. 2.2D) until it eventually returned to pre-CALI 
levels (10-15min after irradiation, data not shown). The same quantification scheme 
applied to cells expressing EGFP-CP (no knockdown) or EGFP alone showed no 
detectable increase in edge content in the irradiated area (Fig. 2.2D).    
 
CALI of EGFP-CP induces a local increase in dorsal F-actin and barbed ends. The 
morphological changes induced by CALI in the KDR cells were consistent with loss of 
actin filament capping activity, but we sought to confirm the underlying mechanism of 
this effect using fluorescent assays of filament growth. To verify that the dorsal 
protrusive structures observed after CALI of EGFP-CP in KDR cells contained F-actin, 
cells were fixed and stained with fluorescent phalloidin after laser irradiation. There was 
perfect co-localization between the phalloidin signal and the dorsal protrusive structures 
observed with CALI treatment (Fig. 2.3A), showing that the dorsal protrusions induced 





Acute loss of CP activity should result in an increased number of barbed ends and 
enhanced filament growth. To test for increased numbers of barbed ends after CALI of 
EGFP-CP, we utilized a fluorescent assay that specifically detects them. This assay 
involves gently permeabilizing cells and adding fluorescently labeled actin monomers 
that polymerize onto free barbed ends in situ. Following fixation, the fluorescent signal 
quantitatively reports the density of free or growing barbed ends in a particular cellular 
location104. We compared the barbed end signal of the irradiated region with similar non-
irradiated regions in the CALI-treated cells. CALI of EGFP-CP in KDR cells produced a 
two-fold average increase in barbed ends where the cells were irradiated (Fig. 2.3B and 
Figure 2.3. CALI of EGFP-CP in KDR 
cells generates a local increase in barbed 
ends of actin filaments and dorsal F-actin. 
(A) DIC image (left panel), fluorescent 
image of Alexa568-labeled phalloidin from a 
deconvolved three-dimensional stack (center 
panel), and overlay (right) from an EGFP-CP 
KDR cell after CALI, area of irradiation is 
represented by the red circle, scale bar is 
20µm.The bottom panels are zoomed 
versions of the top panels. (B) Fluorescent 
image of EGFP-CP immediately after laser 
irradiation (left) and a pseudocolored 
fluorescent image of actin filament barbed-
ends labeled with Alexa568-conjugated G-
actin at 3 minutes post-CALI. (C) Graph 
showing the relative barbed end increase in 
the irradiated regions of Rat2 fibroblasts 
expressing the following contructs: EGFP (n 
= 12), EGFP-CP KDR (n = 19), EGFP-CP 
no KD (n = 7), EGFP-Mena (n = 9), and 
Mena/VASP null MEFs (MVD7 cells) 
expressing EGFP-Mena (n = 5), error bars 
are 95% C.I, asterisk indicates p < 0.01 
compared to all other groups (Tukey’s HSD 
post-hoc test; ANOVA p = 6.8 × 10-8). 
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C), while there was no detectable increase when we irradiated non-knockdown cells 
expressing EGFP-CP or soluble EGFP (Fig. 2.3C). As an additional control to ensure that 
the local barbed end increase was due to bona fide CP loss of function and not to non-
specific damage caused by irradiating EGFP at the ends of actin filaments, we also 
irradiated EGFP-Mena in Rat2 and in Mena/VASP null fibroblasts (MVD7 cells). In both 
cell lines, no significant barbed end increase was observed in the irradiated area (Fig. 
2.3C).  
 
CALI of EGFP-Mena in rescued deficient cells induces larger, more stable 
lamellipodial protrusions. To verify the increased effectiveness of EGFP-CALI in the 
absence of endogenous proteins, we performed CALI of EGFP-Mena in the Mena/VASP 
null MVD7 cells. Loss of Mena/VASP at the leading edge of migrating cells results in 
altered lamellipodial dynamics: lamellipodia protrude more slowly and persist for longer 
periods, which correlates with faster whole cell migration speeds.93 MVD7 cells rescued 
with EGFP-Mena were irradiated for 300ms with a laser power of 6.1 mW/µm2 
distributed over a 5µm diameter beam. Irradiation parameters were changed from the CP 
experiments because FRAP analysis of EGFP-Mena revealed less total recovery and 
slower recovery kinetics than EGFP-CP (Table 2.1), indicating that CALI could be 
performed in smaller regions. Also MVD7 cells are approximately 50% smaller than Rat2 
fibroblasts. Lamellipodial protrusions were analyzed using kymography, which 
characterizes the kinetic signature of lamellipodia undergoing cycles or protrusion and 
retraction.40, 95  
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Figure 2.4. CALI of EGFP-Mena in Mena/VASP deficient cells induces more 
stable lamellipodial protrusions. (A) Phase contrast image of an MVD7 cell (B) 
fluorescent image of EGFP-Mena immediately after laser irradiation and (C) 
kymograph of a representative EGFP-Mena CALI experiment (A) area of irradiation 
is indicated with the black circle, the line used to generate the kymograph in is 
indicated by the white line. (C) horizontal scale bar is 3min, vertical scale bar is 
5µm. (D) Box and whisker plots displaying results from kymograph analysis. 
Kymographs were drawn in the irradiated regions of cells expressing either EGFP-
Mena (34 protrusions before CALI, 38 protrusions 0-5min after CALI, 34 
protrusions 5-10min after CALI, n =11 experiments), or EGFP (39 protrusions 
before CALI, 49 protrusions after CALI, n =9 experiments), and also in the non-
irradiated regions of cells expressing EGFP-Mena (37 protrusions before CALI, 53 
protrusions 0-5min after CALI, n = 11 experiments). The top whisker indicates the 
90th percentile, the top line of the box is the 75th percentile, the middle line of the 
box is the 50th percentile, the bottom of the box is the 25th percentile, the bottom 
whisker indicates the 10th percentile, the mean is indicated with the dotted line, and 
outlying points are shown as closed black circles, p-values for EGFP-Mena 
experiments are Tukey’s HSD post-hoc test (persistence ANOVA p = 0.01, velocity 
ANOVA p = 0.02), p-values for all other experiments are from student’s t-test. 
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One of the hallmarks of using CALI to subcellularly inactivate target proteins is 
that the effect should be reversible providing that there is sufficient exchange of non-
irradiated and irradiated protein: fluorescence recovery is indicative of nondamaged 
protein entering the effected region. FRAP analysis of EGFP-Mena revealed that there 
was a substantial local exchange of Mena (Table 2.1). [Note that while lateral transport of 
“unCALI’ed” protein is a requisite step in local functional exchange, additional reactions 
at barbed ends may delay the complete restoration of functionalilty.] 
To test for reversibility of the CALI effects, protrusion parameters from these 
experiments were grouped into three categories: before CALI, 0-5min after CALI, and 5-
10min after CALI. Irradiation of EGFP-Mena at the leading edge resulted in a transient 
change in lamellipodial dynamics: protrusion persistence increased while protrusion 
velocity decreased in the first 5 min after CALI (Fig. 24C and D). This occurred in a 
manner that was consistent in direction and magnitude with previously published 
results.95 Both protrusion parameters returned to pre-CALI levels 5-10 min after 
irradiation (Fig. 2.4C and D), showing the CALI effect was in fact reversible. Also, the 
effect was limited to the subcellular area that was irradiated as no effect on lamellipodial 
dynamics was observed in non-irradiated regions (Fig. 2.4D). To test for nonspecific 
effects of local fluorophore excitation, we irradiated MVD7 cells expressing soluble EGFP 






Table 2.1 Cytoplasmic mobility of Capping Protein and Mena 
Protein Cell line Percent Recovery t1/2 (s) n 
EGFP-CP Rat2 EGFP-CP KDR 69.2 ± 1.9 6.6 ± 0.4 14 
EGFP-Mena MVD7 50.3 ± 5.6 17.4 ± 3.9 10 
Values are reported ± s.e.m 
 
Discussion 
Our results support a number of important conclusions about the use of EGFP as a 
CALI chromophore and more generally about the CALI technique. First, despite its low 
efficiency production of reactive photoproducts, our studies demonstrate that EGFP can 
be an effective CALI chromophore, confirming previous work.31, 32 Using two different 
proteins, we show that light-induced inactivation of functional EGFP-fusions lead to 
expected loss of function phenotypes. Second, EGFP-CALI can lead to highly selective 
protein inactivation without significant non-specific photodamage. In the two examples 
of CALI reported here, the loss of function phenotypes induced by CALI led to positive 
changes in cellular structures or behaviors, suggesting that the effects are highly specific. 
Third, CALI of some proteins requires the elimination of unlabeled endogenous protein 
to be effective. Our knockdown/rescue lentivirus system will greatly facilitate the 
generation of cell lines meeting this criterion. Finally, different proteins will require 
empirically developed CALI regimes based on the rate of exchange between bound 
protein and the cytosolic pool as well as the diffusional mobility of the protein in the 
cytoplasm.  
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Is EGFP a suitable live-cell CALI chromophore? The answer is yes, but it must be 
recognized that EGFP is a low efficiency photosensitizer and requires excitation with 
intense light to achieve CALI.  Neither a 100W mercury arc lamp nor laser scanning 
confocal illumination produced CALI phenotypes in the EGFP-CP KDR cells (data not 
shown). At this juncture, suitable irradiation sources for EGFP-CALI include focused 
488nm laser light from high-powered Argon ion lasers or multiphoton excitation using a 
frequency doubled Ti-sapphire laser.32 However, the high-energy requirements of EGFP-
CALI hold a hidden benefit: routine imaging and protein inactivation can be performed 
separately since very distinct excitation regimes are required for normal imaging and 
target inactivation. Newly developed fluorescent proteins such as Killer Red produce 
reactive photoproducts much more efficiently, and therefore illumination must be 
carefully controlled to avoid unintended photodamage during imaging.33  Moreover, since 
many functional EGFP fusions already exist, this technique can readily be applied to 
many proteins with minimal time spent generating new reagents.  
Is protein inactivation by EGFP-CALI specific? Since most previous examples of 
CALI resulted in the loss of a cellular structure or disruption of a process, it was easy to 
dismiss them as resulting from non-specific photodamage or phototoxicity rather than 
specific protein inactivation. In the case of Capping protein and Mena, these proteins 
restrain or inhibit cellular processes and inactivation by CALI leads to positive changes 
in cellular properties. It is highly unlikely that non-specific photodamage could account 
for our observed positive cellular phenotypes. Because non-specific damage is such an 
important concern with this technique, extensive controls were performed that ensured 
that laser irradiation alone had no detectable effects in any of our quantitative phenotypic 
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assays. In the case of CP CALI, irradiation of EGFP-CP in cells without knockdown 
provided the best possible control for non-specific CALI effects as it is the same 
functional protein with identical subcellular localization as the protein that induced the 
loss of function. Together, these results strongly argue against non-specific effects due to 
phototoxicity and support the idea that EGFP-CALI can be used to specifically inactivate 
proteins with high spatial and temporal precision.  
This study is the first demonstration that deficient cells complemented with 
tagged proteins are the ideal setting for a CALI experiment. We have identified a case 
with EGFP-CP where the presence of endogenous protein can completely mask CALI 
loss of function. While EGFP-CALI has been shown to work in cells that retain 
expression of the endogenous protein (eg. α-actinin31), this may reflect a special case 
where the EGFP-tagged protein oligomerizes with the endogenous protein.105 In the 
CALI of EGFP-CP in KDR cells, we were able to use light fluxes that were 84% lower 
than the previously reported CALI of EGFP-α-actinin31 (1.5 mW/µm2 vs. 10.5 mW/µm2, 
respectively) with identical irradiation times, thus showing that EGFP-CALI can be 
achieved with almost an order of magnitude less light delivery.  The increased sensitivity 
of EGFP-CP to CALI is likely due to the fact that all of the CP is fused with EGFP, 
although other factors such as the intrinsic efficiency of protein inactivation due to the 
local protein environment of the EGFP tag may be involved.  
In the case of CALI of CP we found differences between the RNAi knockdown 
phenotype and the CALI phenotype: while long-term depletion of CP generated a mass 
increase in filopodia, instantaneous inactivation of CP produced a large number of 
intrapodia-like protrusions. Both of these phenotypes are consistent with actin 
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polymerization.99, 102 One explanation of this difference is that in the case of CP RNAi, 
the cell has days to upregulate pathways to deal with its lost ability to negatively regulate 
filament growth. For example, it has been recently shown that the actin bundling protein 
fascin is essential for filopodia formation106 suggesting that fascin or other functional 
homologues may be upregulated or activated when CP is knocked down. The dorsal 
protrusions induced by the instantaneous activation of CP with EGFP-CALI may reflect 
true function of CP on the actin network with minimal additional regulation.  In this 
regard, it is of interest that intrapodia in growth cones can be strongly induced by 
washout of cytochalasin D,102 which depolymerizes actin filaments by capping them at 
their barbed ends.107 Thus the washout of the drug would result in rapid “uncapping” of 
actin filaments, a similar event to acute loss of CP through CALI.  It will be of interest to 
compare the complementary effects of CALI and RNAi on other actin binding proteins.  
With the two examples presented in this study, the total number of proteins 
inactivated by EGFP-CALI now stands at five. Our results further validate the use of this 
technique and demonstrate that is a viable and efficient means of generating 
spatiotemporal protein inactivation. Our observation that endogenous, untagged protein 
can mask CALI effects is important for the design and interpretation of future CALI 
experiments. The knockdown/rescue lentiviral vector described in this work should 
greatly facilitate the application of CALI to other proteins. Since EGFP has many 
advantages for imaging and has been widely used to generate functional fusion proteins, 




Generation of CP single-step knockdown/rescue vector. The human CPβ coding 
sequence was amplified by PCR from cDNA and cloned into the pMSCV vector 
downstream of EGFP. A 5’LTR-EGFP-CPβ PCR product was generated by splice-
overlap extension PCR and cloned as a NotI/MfeI fragment into the pLenti-Lox 3.7 
vector108 to produce pLL5.0-EGFP-CPβ.  The CPβ shRNA was generated using the 
target sequence GCACGCTGAATGAGATCTA [referred to as T2 in 99] and was cloned 
into pLL5.0-EGFP- CPβ to produce pLL5.1-shCP-EGFP- CPβ.   
 
Cell culture & generation of CP knockdown/rescue cells. Rat2 and MVD7fibroblasts 
were cultured as previously described.93 pLL5.1-shCP-EGFP-CPβ was used generate 
lentivirus by standard protocols.108 Rat2 fibroblasts infected with this virus were cloned 
by fluorescence-activated cell-sorting and screened for CPβ expression by western blot. 
Antibodies against CPβ (mAb 3F2.3) and α-Tubulin (E7) used for western blotting were 
obtained from the Developmental Studies Hybridoma Bank at the University of Iowa; the 
CPβ antibody recognizes both the rat and human form of the protein.  
 
CALI protocol. EGFP-CP CALI experiments were performed using a Spectra Physics 
164 (Spectra Physics Laser Incorporated) argon ion laser (488nm line, 2W of beam 
power at the laser head) focused onto a 23.4µm diameter spot (1/e2 diameter) through a 
60X 1.45 NA PlanApo TIRF objective (Olympus). Irradiation was controlled with a fast 
Uniblitz (Vincent Associates) shutter. Laser power at the specimen plane dropped to 
625mW due to optical losses and was measured by placing the sensor of a laser powe
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meter (Model FM with LS 10 head, Coherent Inc.) directly above the objective. 
Irradiation time was 100ms, resulting in a 62.5mJ dose of energy for the CALI 
experiment.  Laser light was focused onto the specimen plane through a 488nm laser 
filter set (Z488/10, HQ525/50, Z488RDC, Chroma Technology Corporation), which had 
significantly higher light yield than the filter set described above used to visualize EGFP. 
EGFP-Mena CALI was performed essentially as above with the following modifications: 
laser light was focused on the specimen plane through a 100X PlanApo 1.3 Phase 
objective to produce a spot with a 5.0µm diameter. 525mW of power at the laser head 
resulted in 120mW irradiation power at the specimen plane after optical losses. 
Irradiation time was 300ms, resulting in a total energy dose of 36mJ for the CALI 
experiment. 
 
 Live-cell imaging.  For live-cell experiments, Rat2 cells were plated onto 35mm glass-
bottomed dishes (MatTek Corporation) coated with 10µg/mL fibronectin (Sigma). 
Twenty minutes after plating, media was changed to DMEM without phenol red 
supplemented with 10% FBS, L-glut, and pen/strep. MVD7 cells were plated onto glass 
bottomed dishes coated with 1µg/mL fibronectin and maintained in their normal culture 
medium. Imaging was performed on an Olympus IX81 inverted microscope equipped 
with a 100W mercury arc lamp, a cooled 12-bit digital CCD camera (Sensicam QE, 
Cooke Corporation), and a heated chamber (Werner Instruments) with CO2 flow.  All 
images were acquired with MetaMorph software (Version 6.0, Universal Imaging 
Corporation). Fluorescence imaging was conducted using the following filter sets: EGFP 
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(Z488/10, HQ525/50, Q495LP); Alexa568 (HQ535/50, HQ610/75, Q565LP) (Chroma 
Technology Corporation).   
 
FRAP analysis. FRAP experiments were performed on an Olympus IX81 FV1000 laser 
scanning confocal microscope. A standardized 5.0µm diameter circular region was 
placed at the leading edge of cells. This region was photobleached with the 405nm line 
for 200ms at full power using the tornado scan mode while EGFP fluorescence was 
simultaneously monitored using the 488nm line at 1.0% power and a 2µs/pixel scan 
speed. Images were acquired and analyzed using Fluoview FV10-ASW software 
(Version 1.4a, Olympus Corporation) and exported into Microsoft Excel for further 
analysis. Curve fitting, percent recovery, and half recovery times (t1/2) of photobleach 
corrected values were calculated as described109 using a custom written MATLAB script. 
 
Quantification of dorsal structures using Sobel edge detection. To objectively 
quantify the dorsal activity following EGFP-CALI of CP, DIC images were acquired 
every second with 2 × 2 binning. A MATLAB (Version 7.0, Natick, MA) script was 
written to automatically process the 12-bit grayscale DIC images.  For each frame the 
image was read into memory and convolved with a Sobel edge detection filter. The filter 
is an approximation to the derivative and is consisted of two two-dimensional kernels 
(one horizontal and the other one vertical).110 The sensitivity threshold value of the 
magnitude was set to 6 × 10-4, below which edges are ignored. The convolution output, 
which was a binary image, was then masked by multiplying a binary image of the laser 
spot or annulus to segment the area of interest. The sum of the pixels values of the 
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masked edge image were obtained and normalized to the average of the pre-CALI values 
to create an index of dorsal activity before and after irradiation.  
 
Visualization and analysis of F-actin and barbed ends after CALI. All labeling 
experiments were performed on the microscope stage. To visualize F-actin, cells were 
fixed with 4% paraformaldehyde for 10min , permeabilized with 0.1% Triton-X (in PBS) 
for 5min, and labeled with Alexa568 conjugated phalloidin (Molecular Probes) for 
10min. Images were acquired by taking a 4.5µm Z-series with a 100nm step size and 2 × 
2 binning. To remove out of focus fluorescence, background-subtracted image stacks 
were deconvolved using AutoDeblur (Version 9.2, AutoQuant Imaging Corporation) 
software (adaptive blind deconvolution, 80 total iterations).  
 To visualize barbed ends, cells were permeabilized with saponin buffer (20 mM 
HEPES, 138 mM KCl, 4 mM MgCl2, 3 mM EGTA, 0.2mg/ml saponin, 1% BSA, 1 mM 
ATP, 3 µM phalloidin) for 1 min, washed once in saponin-free buffer, and labeled for 3 
min at 37°C with 0.4 µM Alexa-568-G actin (Molecular Probes). Images were acquired 
by taking a 4.5µm Z-series with a 100nm step size and 2 × 2 binning. To quantify barbed 
ends, background subtracted z-series were condensed into a single image using a 
maximum pixel intensity projection (MetaMorph). A standardized circle with a 12µm 
diameter was placed in the center of the irradiated region and all other homologous, non-
overlapping regions of the cell (1-8 per cell, depending on number of similar regions). 
Average pixel intensity was acquired in these regions and the value for the irradiated 
region was divided by the average value of the non-irradiated region(s).  Images were 
prepared and analyzed using MetaMorph software.  
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Quantification of lamellipodial dynamics. Lamellipodial dynamics were quantified as 
described.95, 111 Images were taken every 3s at 100X with 1 × 1 binning. Only cells 
producing new protrusions every three minutes or less were included in the analysis. 
Single lines were drawn in within the 5µm radius of where the cell was irradiated; 
kymographs were generated and analyzed with MetaMorph software and values were 
exported into Microsoft Excel for further analysis.  
 
Statistical analysis. Single comparisons were made using unpaired student t-tests. 
Multiple comparisons from a single data set were analyzed using ANOVA. Data sets 
found to be significant were then further analyzed using Tukey’s HSD post-hoc test
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Abstract 
Elucidation of complex signaling pathways requires precise spatio-temporal 
information on the activation of key signaling components in live cells and tissues. While 
most current methods for studying protein activity involve expressing the protein of 
interest with fluorescent tags, exogenously expressing and tagging a signaling protein can 
be perturbing. Biosensors that report the activity of unmodified, endogenous proteins in 
live cells have been rare. One of the major obstacles in generating sensors for native 
targets has been the absence of readily available binding reagents that are selective and 
activity-specific. To address this issue we present a novel approach which couples high 
throughput screening for artificial state-specific binding elements with a fluorescence-
based reporting system that turns these elements into biosensors  We have generated a 
biosensor for endogenous Src-family kinases with this method.  Using this new sensor we 
observe the dynamic regulation of Src activity during cell motility and growth factor 
stimulation. This work offers a generally applicable approach to generate new tools to 
study endogenous protein activation in living cells.  
 
Introduction 
Studying unmodified, endogenous proteins in live cells relies on two components: 
a state-specific binder that will bind only to the active form of the target protein and a 
reporter system that will enable visualization of target recognition, thus providing a 
precise readout of timing and location of the activity of the target protein in cells. Earlier, 
we developed a biosensor for endogenous Cdc42 (a small GTPase of the Rho family) 
wherein a domain from Cdc42 effector protein that binds only to the active form of 
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Cdc42 was labeled with a dye that is sensitive to its environment and is designed to report 
protein interactions in live cells.83-85, 112 However, such naturally occurring, specific 
binding domains are often not available, which is a limiting factor to the development of 
new sensors for endogenous targets. It is therefore desirable to generate artificial target 
selective, activity specific binding elements on a made-to-order basis. High throughput 
(HT) screening of a library of binding elements offers the means to achieve this goal. 
Furthermore, HT screening can be combined with our highly sensitive and bright 
fluorescent dyes to build a highly modular and generalizable biosensor scaffold that can 
readily be used to generate multiple sensors. 
One such potential biosensor scaffold is the FN3 monobody (antibody mimic) 
derived from the tenth type III domain of human fibronectin domain III (FN3). FN3 
monobodies are a small (~ 95 residues), thermally stable domains with an 
immunoglobulin-like fold composed of seven beta strands. They are easy to produce and 
manipulate. The beta strands are connected by flexible loops that contain the residues 
which confer the binding specificity of the monobody; the loops can be randomized while 
keeping the core domain structure intact. Libraries of 109-1011 variants have been 
generated113 and can be easily screened via phage display. All of these features combine 
to make the FN3 domain an attractive candidate for a generalizable biosensor design 
(Figure 3.1a).  
  High throughput phage-displayed screening involving randomly varying  a total 
of ten residues in two surface exposed loops has yielded FN3 monobodies that bind 
various SH3 domains, including SH3 domains from Src family kinases (SFKs).113 One of 
the SH3 binders, 1F11 specifically binds to SH3 domains from SFKs and shows no 
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binding to SH3 domains from closely related proteins.113 The current model of Src 
activation suggests that a specific Src SH3 binder can provide the basis for an activity-
specific biosensor for Src. Structural studies have shown that Src kinase activation 
involves attenuation of possibly two intermolecular interactions and an opening up of the 
protein, followed by auto-phosphorylation of a tyrosine (Y416) in the activation loop of 
the kinase114. Therefore, a binder that binds to the SH3 domain of Src should have 
preferentially higher binding to the active form the kinase compared to the inactive form, 
with the expectation that the SH3 domain is likely more accessible in open, active form 
of Src .  
Src family kinases (SFKs) are excellent biosensor targets due their roles as key 
regulators of a variety of signaling networks.115, 116 SFKs regulate various processes like 
cell division, cell migration, survival and are important in major diseases like 
atherosclerosis and cancer.115, 117, 118 They are activated downstream of numerous cell 
surface receptors and in turn regulate a variety of processes through phosphorylating a 
large pool of substrates.119 With regards to actin-dependent processes and cell motility, 
there are numerous instances in which SFKs have been implicated. Src kinases control 
the formation of dorsal ruffles and macropinocytic vesicles in response to growth 
factors.120 Src kinases are also involved in coordinating cell migration and protrusions in 
concert with Rho family GTPases121, 122 by directly regulating the actin polymerization 
machinery through phosphorylation of actin binding substrates including Cortactin and 
the ‘WAVE’ complex,123 gelsolin, and pCAS.124 Additionally, Src activity is involved in 
adhesion turnover especially at regions proximal to the leading edge leading to 
lamellipodial extension.125, 126 Since SFKs are key nodes in multiple pathways and have 
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multiple functions in cells, their activation must be tightly regulated in space and time. 
While Src substrate phosphorylation in cells has been reported,127, 128 we wanted to 
examine the direct activation of endogenous SFKs especially in the context of actin 
reorganization and in cell migration. Using a novel, widely-applicable design strategy 
and an extremely sensitive biosensor we report the direct visualization of spatio-temporal 
activation of Src kinases in living cells. 
 
Results and Discussion 
We examined if 1F11 preferentially binds to the active form of Src kinases using 
pull-down assays with cell lysates from GN4 rat liver epithelial cells. GN4 cells show 
robust Src activation (over basal levels) when treated with the compound ciglitazone 
without changing total Src levels.129 In this assay, hexahistidine-tagged 1F11 or the wild-
type FN3 monobody (used as a non-binding control) was immobilized on Ni-NTA beads, 
incubated with cell lysates and examined for the ability to pull-down endogenous Src. As 
shown in Figure 3.1b, the 1F11 monobody pulls down substantially higher amount of Src 
from ciglitazone treated cells compared to untreated cells, indicating preferential binding 
to the activated form of the kinase. Wild-type FN3 domain or beads alone do not show 
any binding to Src in these assays. Pre-treatment of GN4 cells with the phosphatase 
inhibitor pervanadate dramatically attenuates 1F11 pulldown of Src (Figure 3.1b). In 
many cases, dephosphorylation of Tyrosine 529 is critical for Src achieve its “open” 
activated confirmation. This demonstrates that inhibiting Src from reaching activation 
prevents its interaction with the 1F11 monobody. It also shows that addition of 1F11 does 
not artificially activate Src.  
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Using substrate-based in-vitro kinase assays, we show that the SFKs pulled down 
by the biosensor are active. 1F11 beads that had been incubated with Ciglitazone-treated 
lysates, retained several fold higher kinase activity compared to wt-FN3 beads, control 
beads or even 1F11 beads that had been incubated with untreated lysates (Figure 3.1c). 
This observation once again supports that 1F11 is interacting with activated Src and that 
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Figure 3.1: FN3 domain-based monobody 1F11 shows preferential binding to active 
Src. a) Schematic showing the generally applicable concept of using HT screening to 
identify a state-specific binder for active Src family kinases. In this case, Src SH3 domain 
was used as bait to find binders that binder SFK SH3 domains but show no binding to 
closely related SH3 domains. b) Immunoblot showing the amount of Src that binds to 
immobilized 1F11 or controls in a pulldown assay with GN4 cell lysates as a result of cell 
treatment. Cells were either untreated, treated with vehicle DMSO, Ciglitazone (Cig) or 
Ciglitazone with pervanadate pretreatment. As non-binding controls either beads alone (B) 
or immobilized wild-type FN3 domain (wt FN3) was used for the pulldown. c) Relative Src 
kinase activity in material bound to beads alone, immobilized WT FN3 or 1F11 after 
incubation with cell lysates from untreated or treated GN4 cells. Cells had been treated with 
DMSO, Ciglitazone or Ciglitazone after pervanadate pretreatment.  
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With 1F11 showing preferential binding to the active form of Src, the next step 
was to use this domain to construct a biosensor for Src that could be used in live cells. 
Our strategy involved covalently labeling 1F11 domain with an environmentally sensitive 
dye that would report binding of the sensor to its target. Environmentally sensitive, 
cysteine-reactive merocyanine dyes have been developed in our lab for the purpose of 
reporting protein interactions and are especially suited for live cell imaging owing to their 
brightness, long wavelengths and photostability.112 As several of the dyes report target 
recognition through a change in fluorescence intensity, a second fluorophore was needed 
for ratiometric imaging. The emission from this second fluorophore would be insensitive 
to Src binding, therefore normalizing for changes in cell thickness, concentration of probe 
and uneven illumination.  
Converting 1F11 into a biosensor involved optimizing three aspects of biosensor 
design to obtain a bright sensor with the necessary dynamic range: finding the right dye, 
determining the site for dye labeling and introducing a second fluorophore for ratio 
imaging without affecting target sensing. The details of the optimization will be 
discussed elsewhere but the key findings are summarized here. For introducing the 
second fluorophore, 1F11 was fused to the  fluorescent protein, m-Cerulean.130 In 
addition to providing a ratiometric fluorophore m-Cerulean fusion helped stabilize 1F11 
and other FN3 variants in solution and in cells. A long flexible glycine-serine rich linker 
was used for the m-Cerulean fusion to 1F11 to minimize perturbation.89 We found that 
short linkers adversely affected target binding.  
1F11 contains no cysteine residues for dye-labeling, so we generated several 
different single-cysteine 1F11 fusion proteins. The positions selected for cysteine 
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replacements are shown in Figure 2. In order to reduce the possibility of off-target 
labeling, a surface exposed cysteine (residue 48) on m-Cerulean was also mutated. 
Several merocyanine dyes with varying side groups and donor-acceptor groups were 
examined for response and brightness. The response was evaluated by measuring the 
dye/m-Cerulean emission ratio changes due to purified target Src SH3 binding. Overall, 
Mero 53 (Figure 3.2a) emerged as the most suitable dye in terms of sensitivity and 
brightness. With several known solvatochromic dyes there is a tradeoff between dynamic 
range and brightness but Mero 53 was both sensitive and bright. This was consistent with 
previous studies of solvent-dependent fluorescence.112 After testing different 
combinations of dyes and labeling positions, the version that showed the optimal results 
was 1F11 fusion labeled with Mero 53 at the residue 24 (1F11A24C) (Figure 3.2b). 
Residue 24 is in the ‘BC’ loop of 1F11 close to the putative SH3 binding site.113  
Figure 3.2c shows the ratiometric response (dye emission/mCerulean emission) of 
1F11 biosensor measured with respect to increasing amounts of c-Src SH3. The biosensor 
exhibits a large (~50%) ratiometric increase (dye/FP). The increase in ratio is largely due 
to an increase in Mero 53 emission on target binding (Figure 3.2c); the mCerulean 
emission remains largely unaffected. The increase in Mero 53 emission is likely due to 
the dye experiencing a more hydrophobic environment when the sensor is SH3 bound. 
This is consistent with the dye emission being relatively quenched in polar, protic 
solvents in solvent studies.112 We measured the apparent binding constant of the sensor 
towards its target SH3 from the fluorescence ratio changes (Figure 3.2d). A single-site 
binding analysis provides an apparent Kd of 0.69 µM. This is comparable to the binding 
constant obtained by isothermal titration calorimetry between unlabeled 1F11 and Src 
 52
SH3113 indicating that labeling 1F11 and fusing it to mCerulean with the appropriate 
linker minimally perturbs binding to Src SH3.  To examine if the fluorescence response 
we observe is due to target binding and not an artifact of the sensor design, we generated 
a control biosensor that is lacking a Proline residue on the 1F11 FG loop (1F11P78A) that 
is required for target binding. The 1F11P78A control biosensor showed no response to Src 
SH3 (Figure 3.2d) establishing that the sensor response is indeed due to target binding.  
Figure 3.2. Design and in vitro validation of 1F11 Src biosensor. a) Structure of the 
environmentally sensitive merocyanine dye Mero53 b) Ribbon representation of 1F11 (based on 
FN3 domain structure) showing the residues used for single cysteine substitutions for covalent 
dye labeling. Alanine residue shown in bold was changed to cysteine in the final 1F11 sensor. 
Four residues highlighted with dots were also tested as part of the optimization process. Putative 
target binding loops are shown colored with cyan. Also shown schematically is the fusion of m-
Cerulean to 1F11 via a flexible linker as part of sensor design. c) Mero53 emission change due 
to c-Src SH3 binding. Shown here is emission spectrum (λex 590 nm) of 0.5 µM 1F11 biosensor 
alone (solid line) or with saturating amounts of purified c-Src SH3 domain (dotted line). d) 
Titration showing the change of normalized emission ratio Mero-53/m-Cerulean for 1F11 
biosensor or control (0.5 µM) with increasing c-Src SH3. For dye, λex 590nm and λem 620nm 
while for m-Cerulean λex 433nm and λex 477nm were used.  Control sensor (1F11P78A) has a 






















An important feature of the sensor is that the dye Mero 53 is extremely bright. 
The dyes are solvent sensitive so it is conceivable that they are not at high level of 
brightness when attached to the biosensors. Here, even in aqueous environments where 
dye emission is reduced, the dye emission was twofold greater than the emission from m-
Cerulean. Further, the current sensor works through direct excitation of a high extinction 
coefficient, high quantum yield dye whereas FP FRET-based sensors rely on direct as 
well as indirect excitation of the functional fluorophores. This, in effect, makes the 
current dye-based sensor extremely sensitive in comparison with FRET sensors that have 
been extensively used in cell biology. Sensitivity and brightness of the sensor are 
extremely advantageous for live cell imaging since it is often imperative to minimize 
light exposure and the resultant photo-toxicity, in addition to the ability to visualize 
subtle signaling events. 
We examined the ability of the biosensor to detect Src kinase activation in live 
cells. The sensor was microinjected into NIH 3T3 mouse embryonic fibroblasts (MEF) 
cells which were then stimulated with platelet derived growth factor (PDGF). PDGF 
stimulation of MEFs induces the formation of dorsal ruffles.131, 132 It is known that Src 
activation is necessary for the formation of these large circular actin-based protrusions, 
and that active Src specifically localizes there.120 Using the 1F11 biosensor, we see high 
dye/FP at dorsal ruffles from their induction until they submerge back into the cell body 
or close to become macropinosomes (Figure 3.3a); observation of active Src in these 
structures is consistent with previous findings using immunostaining in fixed cells.120 In 
addition to validating that the biosensor reports local Src activity, this experiment is also 
critical in that it demonstrates that localized Src-dependent processes are not inhibited at 
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biosensor concentrations used for imaging. The brightness of the reporter dye in cells and 
the direct excitation of the fluorophores permit imaging at relatively low biosensor 
concentrations with minimum perturbation. 
We examined Src at the cell periphery. It is also of note that there was no visible 
difference between the protrusive characteristics of cells injected with the biosensor, its 
control, or non injected cells, once again indicating that the presence of the sensor at 
imaging concentrations is not affecting cellular processes. This is important as Src 
activity and proper localization is required for cell migration and spreading. In MEFs, we 
saw high dye/FP ratios in lamellipodia in response to PDGF treatment. To further explore 
this we introduced the biosensor into PTK1 epithelial cells, which form very large, flat 
lamellipodia that constitutively undergo cycles of protrusion and retraction. In PTK1 
cells, we discovered a concise band of high dye/FP ratio (~35% above local background) 
immediately adjacent to the protruding cell edge (Figure 3.3b,c). This band appears as 
soon as protrusions are initiated and disappears when the lamellipodia begins to retract. 
Interestingly, we also observed that the probe itself localized to cell edge protrusions, as 
detected with CFP fluorescence indicating significant enrichment of active Src at the cell 
edge (Figure 3.3d). As an imaging control, we used the 1F11P78A variant of the biosensor 
and detected no change in dye/FP intensity at the cell edge (Figure 3.3c). Specificity of 
1F11 to SFK SH3 domains has been extensively probed in original screening paper. We 
wanted to confirm specificity of the sensor in living cells by examining the effect of Src 
inhibitor PP2 on the sensor signal in cells. As shown in Figure 3.3d, both high dye/FP 
ratio and localization of the probe to the cell edge is immediately abolished subsequent to 
PP2 addition. Though Src is required for protrusions and migration121, 133 and has many 
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known targets involved in actin reorganization,123, 124 it has never been directly shown to 
be active in the lamellipodia. To our knowledge this is the first account of spatio-
temporally localized Src activation in the lamellipodia and demonstrates that this 
activation occurs within 500nm of the cell edge and occurs in concert with protrusion 
initiation.  
Figure 3.3. Spatiotemporal activation of endogenous SFKs in living cells. a) DIC (left 
panel) and Ratio (right panel) images of a PDGF-stimulated NIH 3T3 MEF microinjected 
with the 1F11 biosensor. Scale bar is 20µm. b) Ratio image of PTK1 cell microinjected 
with the 1F11 biosensor. Scale bar is 20µm. c) Linescan analysis of the leading edge of 
PTK1 cell lamellipodia microinjected with either the 1F11 biosensor or a non-binding 
control biosensor. 1F11: n = 10 cells, 166 linescans; 1F11P78A monobody: n = 7 cells, 122 
linescans. Error bars are 95% confidence intervals. Inset shows a representative ratio image 
of a PTK1 cell lamellipodia and line used for linescan analysis, solid white line is 20µm. d) 
DIC (left panels), ISO (1F11 Localization, middle panels), and Ratio (right panels) images 
from representative frames of a movie in which a PTK1 cell microinjected with the 1F11 
biosensor was treated with the Src inhibitor PP2. Scale bar is 10µm. 






















The observation of a distinct band of endogenous Src activation close to the edge 
and the correlation of timing of Src activity with protrusion supports the notion that a 
dedicated pool of Src activity is involved in intricate control of cell protrusion machinery 
through actin cytoskeleton organization as well as adhesion signaling. The nodal role of 
Src is also highlighted by timing of Src activation in ruffles wherein we observe sustained 
bursts of Src activity coinciding with periods of actin organization. Src kinases perform 
multiple functions in cells and respond to different stimuli leading to the expectation that 
cells likely have distinct pools of Src activity. Our results clearly show this phenomenon 
with spatio-temporal resolution. The sensitive sensor offers a powerful tool to interrogate 
network dynamics controlling migration, adhesion and cytoskeletal dynamics. 
In summary, we have demonstrated the efficacy of a generally applicable concept 
wherein HT screening can be used to generate biosensors for endogenous protein targets. 
Using this strategy, we developed a highly sensitive biosensor for endogenous Src family 
kinase activation in live cells. Furthermore, the sensor is modular in nature and this 
concept can now be extended to generate biosensors against multiple targets simply by 
changing the binding specificity of the FN3 domain. Finally, cell imaging using the 
sensor has provided novel insights into the activation dynamics of SFKs. Transient and 
localized Src activation was observed in dorsal ruffles and proximal to the leading edge 
in lamellipodial protrusions. Understanding the timing and location of SFK activation in 






Immunoprecipitation and pull-down assay. The antibodies for total c-Src, B-12 and N-
16, were purchased from Santa Cruz Biotechnology. FN3 monobodies including the 
binder 1F11 and wt FN3 (non-binding control) were expressed in E.coli BL21 (DE3) as 
described previously113. The monobodies having a hexa-His tag were purified using Ni-
affinity columns (His GraviTrap™) purchased from Amersham/GE healthcare as per 
manufacturers instructions, except in some cases a step gradient was used in the elution 
of the proteins from the His GraviTrap™ columns to increase purity.  
The thiazolidinedione, ciglitazone, (±)-5-[4-(1-methylcyclohexylmethoxy)-
benzyl] thiazolidine-2, 4-dione, is a PPAR ligand. Ciglitazone (Biomol) was prepared as 
stock solutions in dimethyl sulfoxide. GN4 cells grown as described above were left 
untreated before lysis, treated with DMSO, or treated with a solution of Ciglitazone in 
DMSO for either 10 or 30 minutes such that the final concentration of Ciglitazone was 50 
µM. In order to inhibit phosphatases in a global manner, GN4 cells were pretreated with 
50µM pervanadate for 5 minutes. For ‘Cig+P’, cells were pretreated with pervanadate, 
before the Ciglitazone treatment as described above. Prior to experiments, cells at 70–
80% confluency were serum-starved overnight in Richter’s minimum essential medium 
containing 0.1% fetal bovine serum. Following stimulation for the times indicated, media 
was aspirated, and the cells were rinsed twice with ice-cold PBS. The cells were then 
scraped into ice-cold RIPA buffer (150 mM NaCl, 9.1 mM Na2HPO4, 1.7 mM NaH2PO4, 
1% Nonidet P-40, 0.5% sodium deoxycholate, and 0.1% SDS, pH 7.4) with freshly added 
200 µM Na3VO4, 250µM phenylmethylsulfonyl fluoride, 5 µg/ml leupeptin, and 10nm 
microcysteine. The cell lysates were clarified by centrifugation at 14,000 rpm for 10min 
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at 4 °C. Protein concentration of the supernatant was determined using the Coomassie 
protein assay reagent (Pierce). 
For pull-down assays, 200 µg of lysates (in RIPA buffer, no SDS) from GN4 
cells, treated as described above, were incubated with 100µg of either 1F11 or wt FN3 
preabsorbed on 15 µL Ni sepharose (Qiagen) beads overnight with gentle agitation, in the 
presence of 20mM Imidazole. The beads were washed once with RIPA (no SDS), thrice 
with ice cold PB and then resuspended in 20µL Laemmeli buffer, boiled for 5 mintes, and 
subjected to SDS-PAGE, followed by analysis by western blots to look at total Src 
pulled-down by either the binder or control proteins. 10 µg of cell lysate was resuspended 
in SDS-PAGE sample buffer (0.5 M Tris, pH 6.8, 4% SDS, 20% glycerol, 10% β-
mercaptoethanol, 0.1% bromphenol blue) and heated at 95°C for 5 min to denature 
proteins. The lysates were then resolved by SDS-PAGE on NuPAGE precast 10% Bis-
Tris or NOVEX Tris-glycine gels (Invitrogen) and transferred to polyvinylidene fluoride 
(Immobilon-P; Millipore). The immunoblots were incubated with the appropriate primary 
antibody overnight at 4°C, washed three times with TBST, and probed with horseradish 
peroxidase-conjugated secondary antibodies for 1h at room temperature. Immunoblots 
were then developed with ECL (Amersham Biosciences) according to the manufacturer’s 
instructions and visualized by autoradiography (Kodak X-Omat Blue film). 
 
In vitro kinase assay. Src kinase activity in Src protein pulled down by either the binder 
(1F11) or wt FN3 from stimulated or unstipulated GN4 cells was measured using a 
commercial Src assay kit (Upstate Biotechnology, Inc.) according to the manufacturer’s 
instructions with slight modifications. Briefly, Src was subjected to FN3 pull-down as 
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described above from 200µg of cell lysate by overnight incubation with either the binder 
or control. Src activity present in FN3-bead complexes was assessed by measuring the 
transfer of the γ-phosphate of [γ-32P]ATP to a specific Src substrate peptide for 10 min at 
30°C. Phosphorylated substrate was then separated from residual [γ-32P]ATP using P-81 
phosphocellulose paper (Whatman) and quantified with a scintillation counter. 
 
Purification and dye labeling of 1F11 monobodies. 1F11-mCerulean fusion proteins 
were expressed in E.coli BL21 (DE3) as described.113 Briefly, 1L cultures were induced 
with 1mM IPTG at RT for 14-16 hours before harvesting the bacteria. The biosensor 
fusion proteins having hexa-His tag were purified using Ni-affinity columns (His 
GraviTrap™, GE healthcare) as per manufacturer’s instructions, except in some cases a 
step gradient was used in the elution of the proteins from the His GraviTrap™ columns to 
increase purity. The proteins were examined for purity using SDS-PAGE. 
Concentrated DMSO solutions of Cysteine reactive merocyanine dyes were added 
to 1F11-mCerulean fusion proteins present in 50 mM HEPES, 100 mM NaCl buffer pH 
7.4 such that the dye was present in 5-10 fold molar excess and the DMSO in the reaction 
mixture was less than 10%. After reaction for 3-4 hours, excess dye was separated from 
labeled protein using size exclusion G-25 (GE Healthcare) columns. Labeled proteins 
were directly visualized after being subjected to SDS-PAGE electrophoresis and a single 
fluorescent band was observed. Also, no free dye was seen after size exclusion, where a 
clear separation was seen between the labeled protein band and the relatively immobile 
free dye. Coomassie labeling was also done to verify homogeneity of the sensor 
preparations. Labeling efficiency was calculated by measuring the d
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concentrations of the labeled conjugate. Dye concentration was estimated using dye 
absorbance at 590 nm (ε = 140,000 cm-1 M-1) while the protein concentration was 
estimated by using absorbance due to the mCerulean FP and its molar extinction 
coefficient of 43,000.134 Labeling efficiency was in the range of 95-100 %. In order to 
minimize the likelihood of mCerulean getting labeled, Cysteine 48 was mutated to 
Alanine. 
 
In vitro biosensor binding assays. SH3 domain of from c-Src was expressed, purified 
and analyzed as described.113 In vitro response of the labeled 1F11 or control monobody 
was tested by recording fluorescence spectra of samples where the biosensor has been 
incubated with increasing concentrations of Src SH3 domain in PBS pH 7.4 at room 
temperature, using SPEX fluorolog 3. Ratio-metric response was measured by recording 
dye fluorescence (λEx = 590nm, λEM = 620nm) as well as the mCerulean fluorescence (λEx 
= 433nm, λEM = 475 nm).  
 
Cell Culture. GN4Rat liver epithelial cells were grown in Richter’s minimal essential 
medium (Gibco) supplemented with 10% heat-inactivated fetal bovine serum and 
penicillin, streptomycin, and amphotericin B. NIH 3T3 fibroblasts (MEFs) and were 
cultured in 5% CO2 at 37°C in Dulbecco’s modified Eagle’s medium (DMEM, 
Mediatech) supplemented with 10 % fetal calf serum, 1 % L-Glutamine, and 1% 
penicillinstreptomycin. PTK1 cells (ATCC# CCL-35) were cultured in DMEM/F12 
media (Gibco) supplemented with 8 % fetal calf serum, 1 % L-Glutamine, and 1% 
penicillinstreptomycin. MEFs and PTK1 cells were imaged in Ham’s F-12K medium 
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without phenol red (SAFC Biosciences) with 2% fetal bovine serum, 15mM HEPES, 1 % 
L-Glutamine, and 1% penicillinstreptomycin. For imaging experiments MEFs and PTK1 
cells were plated onto coverslips coated with 5µg/mL Fibronectin (Sigma) overnight. 
Culture media was exchanged for imaging media for one hour prior to microinjection. 
Cells were microinjected as described83, 86 with a biosensor concentration of 40µM in the 
microinjection needle and were allowed to recover for 30-60min before imaging 
experiments began. MEFs were stimulated using 30ng/mL PDGF (Sigma). PTK1 cells 
were treated with 10µM PP2 (Sigma).   
 
Microscopy. Imaging was performed on an Olympus IX81 motorized inverted 
microscope equipped with ZDC focus drift compensator, a cooled digital 12-bit CCD 
camera (CoolSnap, Roper Scientific), a 100W Mercury arc lamp, and MetaMorph 
imaging software. Images were acquired using a 40X UPlanFLN 1.3 NA oil immersion 
objective or a 60X 1.2 NA UApo N Silicon oil immersion objective. A Multi-pass 
dichroic mirror (89006bs, Chroma) was used with the following band pass filters: CFP 
(ET 436/20, ET 480/40) and ISO (HQ580/30, HQ 630/40).  Images were acquired and 
processed as described.83, 86 To generate activation profiles in protrusions, the linescan 
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Abstract 
During development and regeneration, a growth cone guides the extending axon 
of a neuron through an environment of positive and negative cues until in reaches its 
specific destination. A principal target of these cues is the cytoskeleton and the molecules 
which regulate it. A large body of research has implicated that repulsive cues and 
collapse factors mediate their effects through the small GTPase RhoA.  However, little is 
known about the subcellular regulation of RhoA during normal axon extension and how 
that changes in the presence of a repulsive agent.  Here we utilize a genetically encoded 
biosensor to determine the spatiotemporal activation of RhoA during growth cone 
advance and collapse. We find that RhoA is active in the peripheral domain of migrating 
growth cones, and that this activation is persistently maintained during axon advance. We 
also show that although RhoA levels increase in the growth cone following the addition 
of a soluble collapse factor, they rapidly decrease after the growth cone initiates the 
collapse process while the cell body RhoA levels remain elevated. With novel 
spatiotemporal information, our results provide new mechanistic insight into the role of 
RhoA in growth cone behavior. 
 
Introduction 
There are two prominent instances in which neurons extend axons. The first is 
during embryonic development, when the primary goal of axon growth is to find the 
appropriate dendrite of another neuron to form a synapse. The second is during peripheral 
nerve response to injury. In mammals, the neurons from the central nervous system lack 
the ability to undergo regenerative growth, thus nerve wounding generates permanent 
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effects. In both cases, locally secreted factors stimulate an axon to extend and then guide 
it via its growth cone to its appropriate destination.135, 136 A principal intracellular target 
of these external factors (these include neurotrophins, netrins, ephrins, and semaphorins) 
is the cytoskeleton and the molecules that regulate it, including the Rho-family of small 
GTPases.  
Rho-family GTPases are centrally important regulators of the cytoskeleton. They 
hydrolyze GTP in order to switch between active (GTP-bound) and inactive (GDP-
bound) states. Their activity is negatively regulated by GTPase activating proteins 
(GAPs) and GDP disassociation inhibitors (GDIs) and positively regulated by guanine 
nucleotide exchange factors (GEFs). Thus, Rho-family GTPases act as “molecular 
switches” that can be turned on or off with profound downstream effects.137, 138 Of the 
Rho-GTPases, RhoA is one of the best characterized members. It controls a number of 
behaviors relevant to axon growth, including actin and microtubule dynamics, and 
actomyosin contractility.137  
 The current paradigm is that RhoA is a potent inhibitor of axon growth. In CNS 
injury, locally secreted factors in the wounded region activate RhoA, causing growth 
cone collapse and regeneration failure.139Axon retraction is predominantly mediated 
through RhoA stimulation of actomyosin contractility.140 In experimental spinal chord 
injury models, inhibition of RhoA signaling has led to axon regrowth and partial 
recovery;98, 140 currently the RhoA inhibitor BA-210 is in phase I/IIA trials for treatment 
of spinal chord injury.141  
 However, RhoA-mediated growth cone collapse is also a necessary component of 
guidance and therefore of appropriate forward movement;104, 142, 143 the growing axon 
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must be able to dynamically switch between states of extension and retraction to respond 
appropriately to positive and negative guidance cues. Furthermore, there have been 
studies that have shown RhoA is a positive mediator of growth cone advance in a manner 
separate from its role in growth cone collapse.144-147 These results are counterintuitive to 
the conventional model of RhoA has a growth inhibitor and lead to an important 
outstanding question in the field: how can RhoA both negatively and positively regulate 
axon growth?  
During axon growth, microtubule dynamics are necessary for motility and 
guidance.148-150 In the growth cone, the microtubule cytoskeleton is highly spatially 
organized. The majority of microtubules are localized to the central domain, which is 
immediately adjacent to the axon shaft. These microtubules are stable and relatively non-
dynamic. A small subset of these microtubules invades the transition and peripheral 
domains; these are extremely dynamic, rapidly undergoing cycles of growth and 
shrinkage.103 In growth cones, RhoA is responsible for corralling the microtubules into 
the central domain and for dampening their dynamic behavior.151  
 RhoA has the ability to organize and stabilize microtubules through both direct 
downstream signaling and through indirect effects resulting from actin-microtubule 
coupling. The former occurs through the RhoA effector mDia, which can interact with 
the microtubule tip-binding proteins EB1 and APC.152, 153 The latter results from RhoA 
regulation of actin and actomyosin contractility; these effects generate actin structures 
which can shape and dynamically regulate the microtubule cytoskeleton through physical 
linkage.103, 151 Furthermore, in addition to microtubules being downstream of RhoA, it 
has also been shown that they can act upstream of RhoA activation.144, 154-156 What is 
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unclear in the growth cone is how the relationship between RhoA and microtubules is 
spatially defined, and how this relationship relates to growth cone motility.  
The Hahn lab has engineered a genetically encoded Fluorescence Resonance 
Energy Transfer (FRET) biosensor to directly visualize the activation of RhoA in living 
cells.89 The biosensor is a single-chain design consisting of full-length RhoA that is 
labeled at its N-terminus with YFP, followed by a flexible linker, CFP, and then the Rho-
binding domain (RBD) of Rhotekin. In the inactive GDP-loaded state RhoA does not 
bind RBD, and there is little FRET between the adjacent fluorescent proteins. In the 
active GTP-bound state RhoA interacts with RBD and FRET is increased (Figure 1). By 
leaving the C-terminus of RhoA intact, this biosensor undergoes proper localization and 









Figure 4.1. Localization of RhoA activation in growth cones. a,d Differentiated CAD cells 
and c, primary DRG neuron expressing the RhoA biosensor. a, DIC (left panel) and ratio (right 
panel) images of a CAD cell growth cone, scale bar is 10µm. b, RhoA activation profile in 
CAD cell growth cones (n = 70 linescans, 7 growth cones), error bars are 95% confidence 
intervals. c, ratio image of a DRG neuron, scale bar is 10µm. d, Microtubule (left panel, labeled 
with mCherry-β-Tubulin) and ratio images of a CAD cell growth cone, scale bar is 10µm.  
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Results and Discussion  
We introduced the RhoA biosensor into CAD neuroblastoma cells. These cells 
can be induced to differentiate by serum withdrawal;157 in early differentiation they 
extend axons with motile growth cone-like structures that phenotypically mimic growth 
cones found in primary neurons. In CAD cell growth cones we observe a band of high 
RhoA activation immediately adjacent to the leading edge that gradually tapers to the 
growth cone center where FRET/CFP ratio values are lowest (Figure 4.1a, b). Only 5% 
total change in the FRET/CFP ratio from the growth cone center to the edge was seen in 
CAD cells expressing a control biosensor lacking the Rho binding domain (RBD) (Figure 
4.2a) with no peak near the periphery. Additionally, since RhoA is active at the plasma 
membrane there was a concern that the loss of activity in the growth cone center was a 
volume artifact caused by increased cell thickness in this region. To address this, we 
performed FRET imaging using Total Internal Reflection Fluorescence Microscopy 
(TIR-FM) to obtain a volume independent measurement and once again found the lowest 
FRET/CFP values in the center of the growth cone and the highest in the peripheral 
domain (Figure 4.2b). This broad gradient of RhoA activity at the growth cone periphery 
was also observed in mouse E14.5 DRG neurons (Figure 4.1c). The activation pattern 
observed in growth cones is different than what has been reported in the protruding 
lamellipodia of fibroblasts where all of the activity is contained in the first 2µm relative 
to the leading edge.89 The axon stalk and cell bodies of DRG neurons contained the 
lowest FRET/CFP ratio values (Figure 4.1c). We then co-expressed mCherry-β-Tubulin 
in CAD cells to provide a cytoskeletal reference for growth cone morphology. The 
microtubule cytoskeleton in CAD cell growth cones was organized in a manner 
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consistent with previous studies of primary neurons: the microtubules are largely 
confined in the central domain with a few individual microtubules extending out into 
periphery (Figure 4.1d).  In reference to this marker we see that RhoA activation is absent 
in the growth cone center where microtubules are abundant and increases immediately 
outside of this region (Figure 4.1d), hinting at a functional relationship between RhoA 
and microtubules.      
We also performed time-lapse imaging of growth cones co-expressing mCherry-
β-Tubulin. We observe that when bundles of microtubules are formed in the growth cone 
periphery in association with intrapodia there is a decrease in local RhoA activity levels, 
even in regions adjacent to the leading edge where FRET/CFP ratios are highest (Figure 
4.3a). Combined with the observation that RhoA activity is lowest in the central domain 
where polymerized microtubules are most prevalent (Figure 4.1d) we hypothesized  
Figure 4.2. Controls for localization 
of RhoA activity. a, Activation profile 
of control RhoA biosensor that lacks 
the RBD binding domain (n = 269 
linescans, 26 growth cones), error bars 
are 95% C.I. b, TIRF ratio images of 










that microtubules inhibit RhoA in the growth cone and serve as guides for its pattern of 
activation. To directly test this hypothesis we depolymerized microtubules with 
nocodazole. Following addition of 300nM nocodazole, microtubules that extended past 
the central domain immediately began to retreat away from the growth cone edge (Figure 
4.3b). Simultaneously, the zone of high RhoA activity expanded, invading into the central 
domain where FRET/CFP ratio values were initially low (Figure 4.3b). Linescan analysis 
performed on the same growth cones before and after nocodazole treatment (n= 7) 
DIC β Tubulin RhoA Activity




Figure 4.3. RhoA activation and microtubule polymerization are inversely related in the 
growth cone. a, DIC (left panel), microtubule (center panel) and ratio (right panel) images of 
a CAD cell growth cone, scale bar is 10µm. Arrows indicate regions of enriched microtubules 
(black arrows, center panel), which correspond to areas of low RhoA activity (white arrows, 
right panel). b, Kymographs of microtubule (left panel, psuedocolored) and ratio images from 
a CAD cell growth cone treated with nocodazole, vertical scale bar is 3µm, horizontal scale 
bar is 2min. Red arrow indicates nocodazole addition. c, RhoA activation profile in CAD cell 
growth cones before (blue line) and after (red line) nocodazole treatment (n = 70 linescans 
from 7 cells, the same cells were used for before and after measurements).   
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reveals that the pre-nocodazole peak of RhoA activity extends an additional 3-4µm into 
the central domain before it begins to taper down to lower levels (Figure 4.3c). These 
experiments prove the causal relationship between microtubules and RhoA. Previous 
work has shown that RhoA serves as an upstream regulator of microtubules in the growth 
cone, corralling them into the central domain through generation of actin arcs and 
actomyosin contractility.151 Our results demonstrate that microtubules are also upstream 
regulators of RhoA. Together, this suggests that there is a feedback loop between the two 
components that maintains both the organization of microtubules and the localization of 
active RhoA in the growth cone during axon extension.  
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Figure 4.4. RhoA activation in advancing growth cones. a,b, Differentiated CAD 
cell and c,d, primary DRG neuron expressing the RhoA biosensor during growth 
cone migration. a, nascent CAD cell growth cone undergoing constitutive forward 
movement, scale bar is 10mm. b, Kymograph of growth cone in a, vertical scale bar 
is 10µm, horizontal scale bar is 10min. c, advancing DRG neuron, scale bar is 
10µm. d, Kymograph of a DRG growth cone protrusion, vertical scale bar is 5µm, 




Time-lapse imaging of motile growth cones revealed that this pattern of RhoA activity is 
maintained during axon advance, even in growth cones undergoing long periods of 
constitutive forward movement (Figure 4.4a, b). DRG neurons also exhibited RhoA 
activation during migration (Figure 4.4c). Kymograph analysis of a DRG growth cone 
protrusion shows that RhoA is present at protrusion initiation and remains active for its 
entire duration (Figure 4.4d). These examples provide direct evidence that some RhoA 
activation is associated with positive growth cone motility and edge protrusion and not 






Figure 4.5. RhoA activation during growth cone collapse. a, DIC (top panels) and ratio 
(bottom panels) images of a differentiated CAD cell treated with LPA, scale bar is 10µm. 
LPA was added at time point 0:00. b, Graph of growth cone and cell body RhoA activity 
from the cell in a, growth cone collapse is indicated as a loss in growth cone area (dashed 
line). c, Graph showing average RhoA activity in all growth cones (red line) and cell bodies 
(blue line) (n = 31 growth cones, 24 cell bodies). Yellow bar indicates the average time to 
loss of 5% of initial growth cone area ± 95% confidence intervals (246.1s ± 86.2s). Error 
bars are s.e.m, dotted line indicates p-value of student’s t-test between growth cone and cell 
body values, horizontal dashed line shows p = 0.05.     
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Numerous studies have shown that soluble factors that cause the growth cone to 
collapse mediate their effects through RhoA and its downstream upregulation of 
actomyosin contractility.139 However, there is little known about how RhoA behaves at 
the subcellular level during this process. We utilized differentiated CAD cells to 
investigate the spatiotemporal regulation of RhoA during Lysophosphatidic acid (LPA)-
mediated growth cone collapse. Following addition of 3µM LPA, we see an 
instantaneous and significant response of the biosensor in both growth cones and cell 
bodies (Figure 4.5a-c). No changes in RhoA activity were observed in control 
experiments using cells expressing a mutant biosensor (T19N) stimulated with LPA or 
cells expressing the wild-type biosensor stimulated with a bovine serum albumin (BSA) 
loading control (Figure 4.6). In growth cones, peak RhoA activation occurred earlier than 
cell bodies (Figure 4.5b, c), and on average preceded the initiation of growth cone 
collapse (Figure 4.5c). Following peak RhoA activity, the growth cone FRET/CFP ratio 
values degraded coincident with collapse while cell body RhoA was maintained at an 
elevated level (Figure 4.5b, c; see Figure 4.7a-c for a summary of all LPA experiments). 
At the latter stages of collapse, growth cone concentrations of active RhoA had fallen 
significantly below pre-LPA levels (Figure 4.7d). These results provide a new 
spatiotemporal insight into RhoA-mediated growth cone collapse and make two new 
suggestions as to the mechanism of which it occurs: that sustained elevation of RhoA 
activity in the cell body may play more of a role in collapse and retraction than once 
thought and that elevated RhoA levels in the growth cone are required to initiate but not 
sustain or complete collapse.  
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Figure 4.7. Summary of all LPA-induced collapse experiments. a, RhoA activation 
in all growth cones (n = 31) included in measurement. b, RhoA activation in all Cell 
Bodies (n = 24) included in measurement. c, Growth cone area loss (n = 23) for all 
growth cones included in measurement (includes all growth cones that lost > 5% of 
initial area). d, Graph showing maximum and minimum post-LPA average RhoA 
values in growth cones and cell bodies (n = 31 growth cones, 24 cell bodies). Error 
bars are 95% confidence intervals; p-value was derived from a student’s t-test. 
 
Figure 4.6. Controls for RhoA 
activity change following LPA 
stimulation. Graph shows 
average RhoA activity in cells 
expressing the wild-type (WT) 
biosensor treated with BSA (n = 
9) and cells expressing the control 
biosensor containing the T19N 
dominant negative mutation 





Cell Culture. CAD cells were cultured in DMEM/F12 medium (Gibco) supplemented 
with 8 % fetal calf serum, 1 % L-Glutamine, and 1% penicillinstreptomycin. They were 
imaged in Ham’s F-12K medium without phenol red (SAFC Biosciences) supplemented 
with 15mM HEPES, 1 % L-Glutamine, and 1% penicillinstreptomycin. To induce 
differentiation, CAD cells were plated on coverslips coated with 18µg/mL Laminin 
(Sigma). After 90min, normal culture medium was exchanged for imaging medium. Cells 
were allowed to differentiate for an additional 90-120min prior to imaging. CAD cells 
were transfected 12-24hrs prior to imaging with the appropriate constructs using Fugene 
6 (Roche) according to manufacturer’s instructions. For LPA stimulation experiments, 
CAD cells were treated with 3µM LPA (Sigma). For nocodazole experiments, CAD cells 
were treated with 300nM nocodazole (CalBiochem). DRG neurons were cultured and 
transfected as previously described.150 Imaging was performed approximately 12hrs after 
NGF-induced differentiation in Ham’s F-12K medium without phenol red (SAFC 
Biosciences) supplemented with 5% fetal calf serum, 15mM HEPES, 1 % L-Glutamine, 
and 1% penicillinstreptomycin.  
 
Microscopy. Imaging was performed on an Olympus IX81 motorized inverted 
microscope equipped with ZDC focus drift compensator and TIRFM illuminator, a 
cooled digital 12-bit CCD camera (CoolSnap, Roper Scientific), a 100W Mercury arc 
lamp, and MetaMorph imaging software. Images were acquired using a 40X UPlanFLN 
1.3 NA, 60X 1.45 NA PlanApoN TIRFM objective, or a 60X UPlanFLN 1.4 NA oil 
immersion objective. A Multi-pass dichroic mirror (89006bs, Chroma) was used with the 
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following band pass filters: CFP (ET 436/20, ET 480/40); FRET (ET 436/20, ET 
540/30); and mCherry (HQ580/30, HQ 630/40).  Coverslips were mounted in an 
Attofluor live cell chamber (Invitrogen) placed in a microscope stage with a heated stage 
adaptor (Warner). 
 
Image analysis. FRET/CFP ratio images were calculated after shading correction, 
background subtraction, and binary masking using MetaMorph and MatLab software as 
previously described. To generate activation profiles, the linescan tool in MetaMorph was 
utilized. Linescan analysis was performed as described. In brief, lines were drawn 
perpendicular from the cell edge to the center of the growth cone, then averaged and 
normalized to the values at the growth cone center (center was defined by the last 5 pixels 
of the average of all lines containing at least 30% of all input pixels).  To account for 
growth cone diversity subsequent to nocodazole treatment, linescans were aligned by 
making the starting value the pre-LPA peak rather than the cell edge. To measure RhoA 
activation during LPA stimulation, a polygon was drawn around the region of interest in 
the photobleach-corrected masked ratio image that best included that region for the 
duration of the movies. All pixel values greater than zero were included in the 
measurement. RhoA activation was normalized to the average of the first 10 time points 
prior to LPA addition. Growth cones and cell bodies were photobleach corrected 
separately due to small differences in their rates of bleaching. 
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Focal adhesions are macromolecular complexes that provide a linkage from a cell 
to its external environment. In a motile cell they form, enlarge, and disassemble; these 
processes are essential to and govern cell migration. To better understand the dynamic 
regulation of focal adhesions during cell motility we have developed software for the 
automated detection, tracking, and data extraction of these structures using Total Internal 
Reflection Fluorescence Microscopy (TIR-FM) image sets of fluorescently tagged 
adhesion components. Utilizing this software we can generate high-content data sets that 
include the size, shape, intensity, and position of every adhesion present in a living cell. 
Moreover these properties are followed over time to assess adhesion lifetime and 
turnover rates. Here we apply this analysis to the adhesion component Paxillin in 
migrating NIH 3T3 fibroblasts. We also show how a single point mutation in Paxillin at 
the Jun-kinase phosphorylation site Serine 178 changes focal adhesion size, distribution, 
and rate of assembly. We present this freely available software as a generally applicable 
tool that will advance the understanding of how focal adhesions are dynamically 
regulated in living cells  
 
Introduction  
Focal adhesions (FAs) are sophisticated protein complexes that serve as points of 
integration for both mechanical and chemical signaling, playing a central role in cellular 
adhesion, survival, and motility. They form and disassemble as a mechanism to transduce 
signals. Characterizing how these structures dynamically change is essential for 
understanding processes such as cell migration, which requires that the adhesions are 
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continuously remodeled as the cell moves forward. During motility, new adhesions are 
born at the leading edge of a protruding lamellipodia. These FAs enlarge and then are 
either disassembled at the base of the protrusion in a process known as adhesion 
turnover158 or  become longer-lived structures that are eventually dismantled in the 
retracting tail at the rear of the cell. In this and other FA-relevant processes, FA dynamics 
are highly regulated by structural and signaling molecules.158-160 Alterations in the 
balance of these regulating factors plays a key role in adhesion turnover and thus normal 
cell function.  
Microscopic imaging of FAs has driven a significant portion of our current 
understanding of adhesion dynamics, with methods such as total internal reflection 
fluorescence microscopy (TIR-FM) providing high-resolution images capable of being 
quantitatively analyzed. However, challenges in image capture and downstream analysis 
has generally led to the characterization of only a relatively small number of hand-picked 
adhesions within any given cell158. Recent technical and methodological improvements 
have led to the automated detection and characterization of focal adhesions for 
application in high-throughput screening studies. For instance, Paran and colleagues161 
have reported on the use of a high-throughput high-resolution imaging system to screen a 
plant extract library for effects on adhesion morphology and distribution. The same high-
throughput imaging system was used to perform multicolor analysis on various adhesion 
components162 and used in a siRNA screen against adhesion related genes.163 In these 
instances, researchers were able to obtain molecular signatures of protein components 
within focal adhesions, resolve sub-domains within adhesions, and identify clusters of 
genes that had similar effects on focal adhesion morphology and placement. These 
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studies demonstrate the power of being able to identify and characterize all adhesions 
present within a cell. However, as these approaches rely on cell fixation, critical aspects 
of focal adhesion biology, including spatiotemporal adhesion dynamics, are lost.  
Here we describe a novel system for the quantification of focal adhesion 
spatiotemporal dynamics. This approach utilizes high-resolution (60x, oil-immersion) 
time-series images of living cells generated with TIR-FM. Image sequences are then 
processed through an analysis system that identifies each individual adhesion, tracks their 
movement through time and collects associated properties concerning the location, shape, 
size and intensity. As the birth, lifetime and death of each adhesion is quantified in this 
approach, a thorough picture of global adhesion behavior is captured.  
To demonstrate the power of this approach, we focus on the molecular scaffold 
protein Paxillin, a core constituent of focal adhesions. Through direct interactions with 
both structural and regulatory components, Paxillin serves as a platform for adhesion 
signal transduction.164 A principal regulatory mechanism of Paxillin is phosphorylation, 
with over 40 sites of phosphorylation currently identified.165 Many of these have yet to be 
characterized, but those that have demonstrate strong effects on cell migration. One of 
these is the c-Jun N-terminal kinase (JNK) phosphorylation site Serine 178 (S178). 
Mutation of this residue to Alanine, or inhibition of JNK signaling, inhibits cell 
motility.166, 167 More recently, it has been shown that phosphorylation of S178 enhances 
Paxillin’s interaction with FAK and Tyrosine phosphorylation at residues 31 and 118.168 
Expression of the phosphomimetic Y31D/Y118D Paxillin can rescue the S178A mutant 
phenotype. This and related work hints that JNK phosphorylation of Paxillin is an early 
step in adhesion formation.  
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In this study we use our imaging analysis system to characterize FAs labeled with 
EGFP-Paxillin, generating high-resolution and high-content data sets of adhesion 
distribution, morphology, and turnover in migrating NIH 3T3 fibroblasts. Results 
demonstrate that we can analyze adhesions in an unbiased manner, with typically 103-104 
adhesions analyzed per cell. Utilizing wild-type Paxillin as a baseline for comparison, we 
utilize our software to detect alterations in adhesion spatiotemporal properties in response 
to S178 mutation. Through this we demonstrate that the loss of this single 
phosphorylation site effects adhesion site formation, size and assembly rates; using large 
data sets, even subtle differences are easily detected at a significant level. These results 
further improve our understanding of JNK regulation of Paxillin dynamics as well as 
demonstrating the utility of appropriately designed image analysis systems in the 
characterization of high-content data sets.  
 
Figure 5.1. Automating the analysis 
of focal adhesion images requires a 
multi-stage pipeline. The first row 
shows several representative example 
images of fluorescently labeled 
Paxillin using TIR-FM micrscopy. In 
the second row, a cartoon depiction of 
the segmented adhesions and the cell 
edge are shown. Identification of the 
adhesions in each image allows a set 
of static morphological and 
fluorescence intensity based features to 
be extracted. The third row shows a 
single adhesion (highlighted in red) 
being tracked through the short sample 
time course. The properties of each 
adhesion are tracked over time, 
allowing the large scale dynamics of 




Quantitative Analysis of TIR-FM Images of Focal Adhesions  
To quantify aspects of focal adhesion spatiotemporal dynamic behavior, we first 
generated an NIH 3T3 fibroblast cell line expressing EGFP-Paxillin to label FA and 
myristolated-Red Fluorescent Protein (myr-RFP) to identify the cell edge.  Cells were 
plated on fibronectin and imaged with TIR-FM for 1-4 hours as they exhibited motile 
behavior. We then implemented a multistage image analysis pipeline (Figure 5.1). 
Briefly, FAs were identified and segmented via a watershed-like algorithm (see 
Methods). Static properties of adhesions identified within each individual timepoint are 
quantified and include properties such as area, position and Paxillin intensity. Dynamic 
properties of adhesions, such as velocities and changes in fluorescent intensity, are 
determined by tracking and measuring adhesion properties across time steps/images. At 
each consecutive time step adhesion birth and death events are identified and registered 
by the software.  
An example of the graphical output generated with this approach is shown in 
Figure 5.2, where a single frame of an image time series is shown, with adhesions 
identified through segmentation and highlighted (Figure 5.2A,B). Superimposition of 
adhesions across all 198 image frames from this movie is also shown (Figure 5.2C).We 
determined distributions for several adhesion properties including area, average EGFP-
Paxillin intensity, axial ratio, distance from edge, and longevity (Figure 5.2D). In total, 
over 200,000 adhesion lineages were assessed. These results demonstrate that we are able 
to identify and quantitatively characterize large numbers of adhesions, allowing the 
unbiased assessment of FA behavior.  
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Figure 5.2. Applying quantitative image processing methods to FA images allows 
comprehensive characterization of FA properties. (A) One frame from a 200 
minute movie of NIH 3T3 cells expressing GFP-Paxillin (the scale bar represents 10 
µm). (B) The same cell as in (A), with each adhesion outlined in a different color. (C) 
The entire set of adhesions in an experiment can be visualized by overlaying the 
adhesions from each microscopy image going from the first image collected to the last 
image collected. This example includes the adhesions from 198 images. (D) A large 
range of properties can be extracted from the segmented FA, five samples are 
provided. The area histogram was filtered to only include adhesions with areas less 
than 5µm. The axial ratio histogram was filtered to only include adhesions with an 
axial ratio of 8 or less. The longevity histogram includes all adhesions, while the inset 
only includes adhesions with longevity greater than 20. The histograms include data 
from 21 cells. 
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Figure 5.3. Automated measurement of focal adhesion dynamics. (A) Each of the adhesions 
in the cells is tracked, allowing the position and properties of single adhesions to be assessed. 
Here a single adhesion (in green), the surrounding adhesions (in blue) and the cell edge (in red) 
are followed for 49 minutes. The cell edge is only outlined in the first frame. (B) The intensity 
of EGFP- paxillin in the tracked adhesion in (A) through time. The red line is a smoothed fit to 
the data using the lowess algorithm. (C) The normalized log-linear fit of the Paxillin intensity 
through time during the assembly phase of the adhesion in part (B). The inset depicts several of 
the images from which the Paxillin intensity was gathered. (D) The normalized log-linear fit of 
the Paxillin intensity through time during the disassembly phase of the adhesion in part (B). The 
inset depicts several of the images from which the Paxillin intensity was gathered. (E) The 
assembly and disassembly rates for adhesions whose Paxillin intensity curve fits have R values 
of 0.9 or greater. The top and bottom lines of the boxplots indicate the 3 and 1 quartiles 
respectively, while the bold lines indicate the media values. The whiskers extend up to 1.5 times 
the interquartile range. The scale bar is 10 µm. 
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Kinetics of FA Assembly and Disassembly  
Of particular importance for understanding FA function is the assessment of 
adhesion behavior through time. Figure 5.3A-D shows the process of determining FA 
assembly and disassembly rates for an individual adhesion. Figure 5.3A depicts an image 
series of a single adhesion (highlighted in green) progressing in 1-minute intervals from 
birth through maturation and death. Using time series information, we quantify the 
normalized intensity of each adhesion over its lifespan (Figure 5.3B). Readily apparent 
are the linear assembly and disassembly phases, which are automatically fit to linear log 
scales (see Methods for details). Our results complement previous work showing that 
adhesions assemble and disassemble with linear progression158. We found that the 
assembly and disassembly curves of over 50% of all adhesions analyzed (n = 1183 for 
assembly and n = 1486 for disassembly) could be described by a log-linear fit, showing 
R2 values of 0.79 or better (Figure 5.4). In the example shown in Figure 3, linear 
approximation describes 92.0% and 96.1% of the variance in the rates of intensity 
increase and decrease, respectively (Figure 5.3C, D). In between these two phases we 
define a stable or stationary phase (Figure 5.3B).  
 
 
Figure 5.4. The assembly and disassembly log-linear models fit the Paxillin 
intensity time courses with high R values. The red lines indicate the median R values. 
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We utilized our system to broadly characterize the rates of FA assembly and 
disassembly by repeating the analysis detailed in Figure 5.3A-D on all adhesions 
identified by our software (n = 20 cells). Results were filtered by focusing only on FAs 
having lifetimes of at least 20 minutes and exhibiting near perfect log-linear fits of 
accumulation or decay rates (R2 > 0.9; Figure 3E). These criterion yielded 304 adhesions 
with clearly definable assembly rates and 489 with well-defined rates of disassembly. 
The mean rate of assembly of 0.045±0.024 min
-1
 is 64% greater than that of disassembly 
(0.027±0.014 min-1). It is of note that the unfiltered data set consisting of 1068 
assembling and 1391 disassembling adhesions yielded similar results, with 0.031±0.023 
min
-1
 and 0.020±0.014 min
-1 (assembly 55% greater) determined for the assembly and 
disassembly rates, respectively. While these average rates are slower than earlier 
published reports, the values determined in previous studies can be found within the 
variance of our data set. We now provide a comprehensive picture of the breadth of 
adhesion assembly and disassembly dynamics in these migrating fibroblasts without 
biasing our analysis toward any particular subset.  
 
Spatial Properties of FA Assembly and Disassembly  
Comprehensive analysis of the dynamics of this class of prototypical adhesions 
allows the estimation of rates of assembly and disassembly. While this provides a view of 
FA behavior as a function of time, spatial aspects of FA behavior and dynamics can 
similarly be studied. Using the identical set of adhesions identified in the previous 
Paxillin kinetics analysis, we investigated the spatial property of where adhesions tend to 
be born or die (Figure 5.5). As seen in (5.5A), the vast majority (84%) of these adhesions 
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are born less than 5µm from the cell edge. In contrast, adhesions tend to die further from 
the edge with a mean value of 8.7µm in these experiments (B). This suggests the 
existence of two distinct, but partially overlapping "zones" within which preferential birth 
or death of FAs occurs. When looking at both FA birth/death location and 
assembly/disassembly rate simultaneously, we find that higher assembly rates are 
observed in births that occur near the edge while no obvious effect of spatial location on 
the rate of disassembly is apparent.  
 
Paxillin S178A Mutant Perturbation  
We used mutation of Paxillin (Serine 178 to Alanine) as a system perturbation. As 
discussed earlier, this mutation blocks JNK phosphorylation of Paxillin and has known 
Figure 5.5. Spatial properties of FA positions at birth and death. The data set used for 
this figure consists of adhesions where the assembly and/or disassembly phases fit a log-
linear model with R value of 0.9 or greater. (A) The majority of adhesions are born within 
5µm of the cell edge and the greatest variance in assembly rates are also observed in this 
5µm band. (B) The distribution of the distance of death location from the cell edge 
indicates that adhesion disassembly typically occurs along a broader band from the cell 
edge as compared to the position at adhesion birth. Also, the variance in disassembly rate is 
roughly the same regardless of the position at adhesion death. 
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effects on cell motility. However, the effect of this mutation on adhesion spatiotemporal 
dynamics has not been well characterized.  
We found that the S178A mutation induced a number of significant effects on 
both dynamic and spatial properties of adhesions. The most dramatic of these changes is 
the approximately 38% reduction in the median rate of adhesion assembly (Figure 5.6A). 
We also observe a small (~12%) but statistically significant decrease in disassembly rate. 
Thus the kinetics of FA assembly is strongly affected by this mutation, but in a non-
symmetric manner.  
Figure 5.6 S178A mutation in Paxillin alters adhesion assembly and 
disassembly (A) The median assembly rate is decreased by 38% in the S178A 
mutants (*** indicates p<10-5). (B) The median disassembly rate is also 
decreased by 14% (* indicates p<0.01). (C and D) The median position of 
adhesion centroids at birth (p<0.1) and death (p<0.49) are insignificantly 
affected by the S178A mutation. All p-values were calculated using the 
bootstrapped confidence intervals with 50000 replicates. 
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We previously observed that adhesions in WT cells have different distributions of 
birth and death position relative to the cell edge. In comparison to WT cells, we find that 
the median distance from the edge at birth is greater by 16% in S178A mutants (Figure 
5.6C), but that this difference is not significant due to the high variance of the observed 
distances. There is no significant difference between WT and mutant cells with regard to 
where an adhesions die, suggesting that spatial aspects of the disassembly process (i.e. 
where disassembly occurs) is not dependent and/or sensitive to JNK phosphorylation 
(Figure 5.6D).  
Finally, we did a lifecycle phase comparison between cells expressing WT and 
S178A EGFP-Paxillin. We determine that the S178A mutation causes longer lived 
adhesions that spend substantially longer time in the assembly phase than WT cells. 
There is a slight but significant (p = 0.5) increase in time spent in disassembly as well, 
but no difference in time spent in the stability phase (Figure 5.7). As a whole, our results 
demonstrate the most severe effects of the S178A mutation occur in the assembly phase: 
position at birth, assembly rate, and time spent assembling. 
Figure 5.7.  The assembly and disassembly 
phases in S178A mutant FAs are significantly 
longer than those in the wild-type, while the 
stability phase lengths are unaffected. The 
phase length values include all adhesions where 
the log-linear models fit with a p-value of 0.05 
or less. Error bars indicate 95% confidence 
intervals on the mean phase length as 
determined through 50,000 bootstrap samples. A 
triple asterisk (***) indicates  and single asterisk 
(*) indicates p<0.05. Wild-type N Values: 
Assembly (1057), Stability (456), Disassembly 
(1371); S178A N Values: Assembly (2089), 





We have described the development of a set of computational tools suitable for 
the global characterization of FA spatiotemporal dynamics and are well suited to 
assessing the results of FA signaling network perturbation on adhesion development and 
behavior. The S178A mutation was presented as a case study in applying these tools to 
analyzing complex FA phenotypes. Through this analysis, we were able to show that the 
S178A Paxillin mutant causes significant changes in FA assembly and disassembly rates 
and may help to explain the previously observed migration defects found in cells with the 
S178A Paxillin mutant. These changes indicate that Jun Kinase, via Paxillin, exhibits 
strong control over the entire FA lifecycle.  
The computational tools presented allow the entire lifecycle of FAs to be 
analyzed. These tools include an automated adhesion detection, segmentation and 
tracking system; extracting a range of properties valuable for understanding FA 
development. The system also integrates methods capable of automatically identifying 
the assembly and disassembly phases of the time-lapse sequence of a FA’s properties. All 
Figure 5.8. Mutations affecting the interaction of JNK with 
Paxillin alter the stages of FA development. 
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of these methods were tested using simulated data that replicated many of the observed 
experimental processes, confirming these methods are able to accurately quantify 
adhesion properties under controlled conditions. The robustness of the differences 
detected between the wild-type and S178A mutants is preserved through a range of 
parameter choices for the adhesion detection limit and the minimum length of the 
assembly and disassembly phases. In particular, we note that all of the detected 
differences were maintained when using the complete set of extracted data, i.e. even 
when the data were not filtered for selection of long-lived adhesions. The rate at which 
images were taken in this work also appears to be well over the sampling rate needed to 
accurately measure the assembly and disassembly rates of long-lived adhesions. 
We find that many of the assembly and disassembly rates detected using these 
automated methods encompass the rates determined using manual methods,158 but the 
automated methods greatly increases the number of adhesions quantified. Differences in 
the mean rates detected by manual versus automated searches can be attributed to several 
factors. First, the rates determined using manual methods originate from user-specified 
adhesions of interest. Such adhesions may be chosen based on specific localization 
properties, such as selecting only those adhesions found within protrusions, while the 
presented results do not make any distinction between adhesions present in different 
cellular structures a priori (though the properties of adhesions at particular locations can 
be determined a posteriori). In addition, our analysis focused on long-lived adhesions, 
which might have different properties than those measured in studies of short-lived 
adhesions. Finally, as our software analyzes all adhesions regardless of the brightness of 
the adhesion, we avoid biases that may occur through, for example, preferential selection 
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of large and highly visible adhesions. Thus, the automated methods described greatly 
extend the types of adhesions that can be analyzed, as well as the range of properties that 
can be quantified. 
The spatial properties of FA birth and death also paint an interesting picture that 
suggests that FAs have distinct regions where assembly and disassembly events are most 
concentrated. These assembly and disassembly regions overlap, but remain distinct. The 
greatest concentration of assembly events occur within 1.5µm of the cell edge. The 
assembly event range interestingly coincides with the end of the lamellipodia and the 
beginning of the lamella, where the structure of the actin cytoskeletal network changes 
significantly.  
Analyzing the differences in the FAs of NIH 3T3 cells with and without a 
mutation that eliminates JNK phosphorylation of Paxillin in vivo, we were able to 
quantify significant differences in several relevant FA properties such as the rate of 
adhesion assembly and disassembly. In addition to the strong perturbations observed, 
several subtle changes in FA dynamics and localization were also detected. Measured 
differences in adhesion size were also observed in a recent siRNA screen of FA proteins 
that included JNK knockdown.163 A model of FA dynamics supported by our findings is 
depicted in Figure 5.8. This model illustrates that the intensity of Paxillin during the 
stability period of the FA lifecycle is decreased compared to wild-type fibroblasts (data 
not shown). In this model, the S178A mutation shows distinct effects on both the 
assembly and disassembly phases of FA development, but these effects are different in 
magnitude. Determining what FA development signals are involved in perturbing the 
assembly, stability and disassembly processes is an ongoing process, but these proof of 
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principle TIR-FM experiments demonstrate the capabilities of the software analysis 
system. 
Development of improvements and additional analysis modules related is 
ongoing. In prior studies, analysis of the cell edge velocity has proven to be a robust 
phenotype that can be used to quantify the effect of many different perturbations to the 
signaling networks that control cellular motility.74 Integration of this type of data will 
allow the rates of cell edge movement to be analyzed in terms of FA phenotypes. Such 
studies will help to bridge the gap between the well-developed fields of cell edge analysis 
and FA dynamics. The data sets collected using the software also provide information 
about the specific properties of the adhesions during each phase of their lifecycle. While 
the “distance from cell edge” measure used here displays interesting patterns, the 
application of more powerful spatial statistics methods will allow the more rigorous 
quantification of spatial, as well as spatiotemporal properties. Such spatial methods will 
also be important as additional types of data, including local protein activity levels, are 
added to the experimental data collected.  
We have described a system for quantifying FA dynamics and localization that 
allows high-content screening methods to be applied to understanding the perturbation of 
FA signaling networks. The system was applied to quantifying the differences in FA 
development generated through a single amino acid mutation of the FA scaffolding 
protein Paxillin. Future studies of other FA perturbation methods with high-content 
analysis methods should provide a comprehensive picture of the role of FA signaling 
proteins in the control of FA development and localization. 
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Methods  
Cell Culture  
NIH 3T3 fibroblasts (MEFs) and 293 LinXE ecotropic packaging cells were 
cultured in 5% CO
2 
at 37°C in Dulbecco’s modified Eagle’s medium (DMEM, 
Mediatech) supplemented with 10% fetal calf serum, 1% L-Glutamine, and 1% 
penicillinstreptomycin. Fibroblasts were imaged in Ham’s F-12K medium without phenol 
red (SAFC Biosciences) with 2% fetal bovine serum, 15mM HEPES, 1% L-Glutamine, 
and 1% penicillinstreptomycin.  
To make stable cell lines, retroviral vectors were transfected into 293 LinXE cells 
plated in 6cm dishes with Fugene 6 (Roche) according to the manufacturer’s protocol 
(using 18µL Fugene 6 and 8µg of DNA). The media was replaced after 12 hours. Viral 
supernatant was harvested 48 hours after media replacement, passed through a .45µm 
syringe filter and then added to MEFs plated at subconfluent densities at a ratio of 1:3 
(viral supernatant/normal media). Cells were simultaneously infected with virus 
containing myr-RFP and the appropriate EGFP-Paxillin construct and went through 5-8 
rounds of infection to reach expression levels sufficient for live cell imaging.  
 
Microscopy  
Prior to imaging, MEFs were plated onto coverslips coated with 5µg/mL 
Fibronectin (Sigma) for 30min. Fibroblasts expressing EGFP-PaxS187A required 2-3 
hours to adhere to the coverslips due to a spreading defect. Immediately before being 
transferred to a sealed imaging chamber, complete culture media was replaced with 
imaging media.  
Imaging was performed on an Olympus IX81 motorized inverted microscope 
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equipped with ZDC focus drift compensator and TIRFM illuminator, a 60X 1.45 NA 
PlanApoN TIRFM objective, a cooled digital 12-bit CCD camera (CoolSnap, Roper 
Scientific), a 100W Mercury arc lamp, and MetaMorph imaging software. The 488nm 
laser line from a Krypton-Argon ion laser (Series 43, Omnichrome) was controlled with a 
custom laser launch/AOTF (LSM Technologies).  
TIRF images of EGFP and epifluorescence images of RFP were acquired using an 
80/20 (TIRF / Epifluorescence) splitter mirror, a custom dichroic mirror (Chroma) and 
the following band-pass filters: EGFP (HQ 525/50); RFP (HQ580/30, HQ 630/40). 
Images were acquired with 2 x 2 binning. Illumination intensity was controlled with 
either the AOTF (TIRF excitation) or neutral density filters (epifluorescence excitation) 
until 300-1000ms exposures satisfied the dynamic range of the camera without saturation.  
Image Processing  
Methods to identify the FA were adapted from a prior publication169, with some 
modification. Briefly, each image taken during an experiment was high pass filtered, 
using a round averaging filter with a radius of 11 pixels (4.95µm diameter). The high 
pass filtered images were threshholded by an empirically determined value set to identify 
adhesion pixels. The water segmentation method was used as described, but with the 
following modifications. When a pixel acts as bridge between two large adhesions, where 
large is defined as 40 or more pixels (1.85µm2), the bridge pixel is assigned to the 
adhesion whose centroid is closest to the bridge pixel. Also, following addition of all 
pixels whose high passed image value was above threshold, pixels surrounded by 
adhesions were identified and added to adhesion set using the same water algorithm. 
Between 200 and 600 adhesions were found in each image from the experimental data. 
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With each focal adhesion identified all the collected images, many static adhesion 
properties are collected (Table 2).  
Average local background fluorescence was subtracted from the average 
fluorescence of each adhesion to give the background correct fluorescence intensity. The 
local background region for a single adhesion was defined as the region within 10 pixels 
of the adhesion border. Pixels outside the cell, inside another adhesion or the adhesion 
itself were excluded from the average background fluorescence calculation.  
The cell edges were found by analyzing the myr-RFP images using a method 
similar to that described in a prior publication.170 Briefly, a histogram of all the intensity 
values for a single image was collected and split into 1000 equal sized bins. The counts 
of each bin were then smoothed with the loess algorithm (Polynomial order 2, 5% of data 
included in each fit) and the minima and maxima of the smoothed fit found. The maxima 
with the highest value was identified and the set of minima at intensity values greater 
than that the highest maxima collected. The intensity value of the minima closest to the 
highest maxima in intensity was used as the binary threshold cutoff for identifying the 
cell edge. Connected regions smaller than 10 pixels were discarded and all the holes in 
the binary cell edge image filled.  
FA Tracking  
With the focal adhesions identified in each image of the experimental data set, 
another series of algorithms were designed to track the focal adhesions through each 
sequential image. The tracking algorithm is based on a birth-death model of a FA 
lifetime. In each sequential image a FA can either be born, continue into the next time 
step, merge or die. The birth-death-merge processes are detected by examining the 
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properties extracted from the segmented adhesions. The results of this tracking algorithm 
are assignments of the FA identified in each image into lineages that track the 
development of the FA during the course of the experiment.  
The tracking algorithm is initialized with all the adhesions detected in the first 
frame of the image sequence. The first step of the tracking algorithm attempts to locate 
FA that correspond to one another in the next time step of the experimental data (Figure 
Supplemental 1). This first step assumes that if a focal adhesion overlaps with a focal 
adhesion in the following frame, that these overlapping adhesions correspond to one 
another. When an adhesion overlaps with more than one adhesion in the following frame, 
the adhesion with the greatest percentage of overlap is assigned as the match in the next 
frame. If a FA does not overlap with any of the FA in the following image, the FA closest 
to that adhesion in terms of the Euclidean distance between each adhesion’s centroid is 
assigned as a match. Adhesions in the next frame that are not selected via either of these 
methods, but still overlap with an adhesion in the current frame are marked as being 
created via a split birth event. Adhesion births that are the result of split events are dealt 
with in later filtering steps. All of the living focal adhesions are assigned a corresponding 
FA in the following image by these two rules.  
This process of assigning live adhesions to corresponding adhesions in the 
following frame produces sets of adhesions that are predicted to merge. Some of these 
merge events are true merge events where one adhesion has joined with another, while 
others are adhesions which die, but are erroneously assigned as merge events. When a FA 
does not overlap with the FA it is predicted to become, this FA is assumed to have died 
and its lineage is ended. These adhesions are also marked as having undergone a death, 
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which will be used in later filtering steps. For the remaining merge events where more 
than one adhesion has been predicted to merge in the next frame, one of the merging FA 
lineages is selected to continue, while the other FA lineage is predicted to end. When the 
adhesions predicted to merge differ in size by at least 10%, the larger adhesion’s lineage 
is continued. If the merging FAs sizes do not differ by at least 10%, the lineage whose 
current centroid is closer to the adhesion centroid in the following image is predicted to 
continue. By this sequence of rules, each merge event is resolved so that corresponding 
FA in adjacent experimental data images are collected.  
Following tracking live adhesions and resolving the merge and death events, there 
remain FA in the following image which are not assigned to any of the current lineages. 
The unassociated FA are assigned into new lineages. This process of tracking the live 
adhesions, resolving merge and death events and starting new lineages is repeated for 
each image in the experimental data sequence until adhesion data from all the images has 
been included.  
Calculating Assembly and Disassembly Rates  
With the adhesions tracked through each experiment, the static properties 
determined for each adhesion in each frame of the time-lapse movie can be collected into 
a set of time series representing the properties of each adhesion through time. One type of 
time series follows the mean intensity of Paxillin through time, making it possible to 
estimate the rates of assembly and disassembly of Paxillin for each adhesion. An 
automated method to estimate the rates of assembly and disassembly was developed. This 
program automatically fits linear models to the log-transformed time series of Paxillin 
intensity values for both the assembly and disassembly phases of the FA life cycle.  
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In the first part of the algorithm, linear models are fit to all the possible assembly 
and disassembly phases of at least a user specified length. The assembly phase is 
assumed to occur at the beginning of the time series, whereas the disassembly phase is 
assumed to end with the last point in the time series. Each of the fits collected were 
normalized by the either first or last point in the time series and log-transformed, as 
described.158  
In the second part of the algorithm, the optimum lengths of the assembly and 
disassembly phases were determined via a search for the maximum sum of adjusted R2 
values of the fits. It was assumed that the assembly and disassembly phases did not 
overlap. In the rare cases where there are multiple combinations of assembly and 
disassembly times that produce the highest sum of adjusted R2 values, the combination 
with the longest combined assembly and disassembly times is selected.  
Results Filtering  
Several filters are used to analyze the data sets collected with these analysis 
methods. When determining the assembly and disassembly rates, only adhesions with at 
least 20 Paxillin intensity time points were analyzed. This ensured that there was 
sufficient data available to correctly detect assembly and disassembly rates. Adhesions 
whose birth was the result of a split event were also excluded from the assembly rate 
calculations, while adhesions whose lineage ended with a merge event were excluded 
from the disassembly rate calculation. Assembly and disassembly fits whose linear model 
p-values were above 0.05, indicating that the slope of the linear model was not 
significantly different from zero, were also excluded from the data set. Several figures 
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only include data from the assembly or disassembly fits whose linear models fit with an 
R
2 
value of 0.9 or greater.  
A separate set of filters were used to compile the stability phase of the adhesion 
lifetime data. In order to estimate the length of time an adhesion spends in the stability 
phase, both the assembly and disassembly phases have to be observed. There are few 
adhesions where both the assembly and disassembly phases fit log-linear models with 
high R
2 
values (above 0.9), so the R2 value requirements were excluded, but the filter did 
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